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DISSERTATION 
ABSTRACT OF DISSERTATION 
DIFFUSE OPTICAL MEASUREMENTS OF HEAD AND NECK TUMOR 
HEMODYNAMICS FOR EARLY PREDICTION OF CHEMO-RADIATION 
THERAPY OUTCOMES 
 
Chemo-radiation therapy is a principal modality for the treatment of head and neck 
cancers, and its efficacy depends on the interaction of tumor oxygen with free radicals. In 
this study, we adopted a novel hybrid diffuse optical instrument combining a commercial 
frequency-domain tissue oximeter (Imagent) and a custom-made diffuse correlation 
spectroscopy (DCS) flowmeter, which allowed for simultaneous measurements of tumor 
blood flow and blood oxygenation. Using this hybrid instrument we continually measured 
tumor hemodynamic responses to chemo-radiation therapy over the treatment period of 7 
weeks. We also explored monitoring dynamic tumor hemodynamic changes during 
radiation delivery. Blood flow data analysis was improved by simultaneously extracting 
multiple parameters from one single autocorrelation function curve measured by DCS. 
Patients were classified into two groups based on clinical outcomes: a complete response 
(CR) group and an incomplete response (IR) group with remote metastasis and/or local 
recurrence within one year. Interestingly, we found human papilloma virus (HPV-16) 
status largely affected tumor homodynamic responses to therapy. Significant differences 
in tumor blood flow index (BFI) and reduced scattering coefficient (μs’) between the IR 
and CR groups were observed in HPV-16 negative patients at Week 3. Significant 
differences in oxygenated hemoglobin concentration ([HbO2]) and blood oxygen 
saturation (StO2) between the two groups were found in HPV-16 positive patients at 
Week 1 and Week 3, respectively. Receiver operating characteristic curves were 
constructed and results indicated high sensitivities and specificities of these 
hemodynamic parameters for early (within the first three weeks of the treatment) 
prediction of one-year treatment outcomes. Measurement of tumor hemodynamics may 
serve as a predictive tool allowing treatment selection based on biologic tumor 
characteristics. Ultimately, reduction of side effects in patients not benefiting from 
radiation treatment may be feasible. 
 
Key words: near-infrared, diffuse optics, head and neck cancer, papilloma virus status, 
radiation therapy, tumor hemodynamics, prediction of treatment outcomes 
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CHAPTER 1 INTRODUCTION 
1.1 Head and Neck Cancers 
Head and neck cancer accounts for about 3 to 5% of all cancers in the United 
States with 40,000 new cases diagnosed each year [1, 2]. These cancers are more 
common in men and in people over age 50. More than 90% of head and neck cancers 
begin in the squamous cells that line the moist, mucosal surfaces inside the head and neck 
area, e.g., oral cavity, pharynx (oropharynx, nasopharynx and hypopharynx), larynx, 
paranasal sinuses and nasal cavity [3]. These head and neck squamous cell carcinomas 
(HNSCC) frequently spread to the lymph nodes in the neck. The major risk factors for 
HNSCC are tobacco use, alcohol consumption, and infection with human papillomavirus 
(HPV); over 75 percent of head and neck cancers are caused by tobacco and alcohol use 
[4]. Human papillomavirus (HPV) has been found in head and neck cancer from all sites 
with a higher prevalence in oropharynx cancer [5]. The incidence of oropharyngeal 
cancers caused by HPV infection in the United States is increasing [6]. In clinical 
practice, HPV-16 immunohistochemistry (IHC) is recommended for detection of HPV 
DNA in tumor cell nuclei [7]. 
1.2 Radiation Therapy 
The three main types of treatment for managing head and neck cancer are 
radiation therapy, surgery and chemotherapy. Radiation therapy is often used as the 
principal modality in the treatment of head and neck cancers [8]. One significant 
advantage of radiation therapy is that it allows for the possibility of organ preservation 
when surgery may seriously affect important functions such as speech and swallowing. It 
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is usually given in combination with chemotherapy (called chemo-radiation) if the stage 
of the cancer is advanced (stage III or stage IV). 
 
Figure 1.1 Direct and indirect action of x rays. In direct action a secondary electron 
resulting from absorption of radiation interacts with the DNA to produce an effect. In 
indirect action the secondary electron interacts with water molecules to produce free 
radicals, which produce the damage to the DNA. 
 
Although the exact mechanism is unclear, accumulating evidence suggests 
double-stranded breaks of nuclear DNA as the most important cellular effect of radiation 
therapy [9]. Damage to a cell can come from direct action or indirect action of the 
ionizing radiation. In direct action a secondary electron resulting from absorption of 
radiation interacts with the DNA to produce an effect. In indirect action the secondary 
electron interacts with other atoms or molecules in the cell (particularly water) to produce 
free radicals, which diffuse far enough to produce the damage to the DNA (Fig. 1.1). X 
rays are considered low linear energy transfer (LET) (sparsely ionizing) radiation and 
cause damage predominantly through indirect actions. Specifically, approximately two 
thirds of DNA damage is caused by indirect action resulting from interaction of x rays 
with water molecules which comprise the majority of the cell (80%) [10]. 
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A free radical is an atom or molecule carrying an unpaired electron in the outer 
shell and is associated with a high degree of chemical reactivity. As an example of free 
radical formation, when x rays pass through living tissue, first electrons are removed 
from water molecules to produce H2O
+
 ions. 
H2O + hν → H2O
+
 + e
−
 
H2O
+
 is an ion radical because it is both an ion and a free radical. The ion radicals 
have an extremely short lifetime (on the order of 10
-10
 second) and decay to then form the 
free radicals, which are not charged but have an unpaired electron. 
H2O
+
 +H2O → H3O
+
 + OH· 
The hydroxyl radical, OH·, is a highly reactive free radical. It can diffuse a short 
distance to attack DNA, break chemical bonds, and initiate chemical changes that results 
in biological damage.  
Radiation therapy tends to kill fast dividing cancer cells, but it also affects 
dividing cells of normal tissues [11]. Radiation therapy is a balance between destroying 
the cancer cells and minimizing damage to the normal cells. 
1.3 Effects of Oxygen on Radiation Therapy 
The radio-resistance of hypoxic cells to ionizing radiation is the primary reason 
for treatment failure in tumors with high levels of hypoxia and is attributed to a reduction 
in the amount of DNA damage under low oxygen conditions. DNA damage can be 
chemically restored under hypoxia through reaction with a sulfhydryl (SH) group. 
However, in the presence of molecular oxygen, oxygen fixes the radical lesions in DNA 
in a form that cannot be easily repaired. This can be expressed as 
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R· + O2 → RO2·→ ROOH → Damage fixation      Cell death  
This is known as the oxygen fixation hypothesis [11]. Here R· is the target (DNA) 
free radical, which has arisen from direct or indirect radiation damage to the DNA of the 
cell. The oxygen enhancement ratio (OER) is defined as the ratio of radiation doses 
during lack of oxygen compared to no lack of oxygen for the same biological effect. The 
OER for x rays is about 2.5 to 3 [11]. In other words, x-ray radiation is 2.5 to 3 times 
more effective at killing cancer cells under well-oxygenated (normoxic) conditions as 
compared with under hypoxic conditions. To exert its sensitizing effect, oxygen must be 
present during or within milliseconds after the radiation exposure delivery of the 
radiation dose [12]. The condition of the vascular ecosystem surrounding a tumor (tumor 
microenvironment) can therefore greatly influence the efficacy of radiation therapy. 
1.4 Tumor Hypoxia and Blood Supply (Flow) 
Hypoxia is one of the most important features in the tumor microenvironment and 
is often implicated as a primary cause of treatment failure following radiation therapy 
[13]. As described above, it is associated with tumor radio-resistance. Hypoxia may also 
lead to a reduction in levels of DNA repair proteins, potentially reducing DNA repair 
capacity, and enhancing the possibility of genomic instability [14]. This genomic 
instability can lead to tumor cell variants that can survive in an oxygen depleted 
environment through clonal selection and expansion and result in a more clinically 
aggressive phenotype with increased invasive capacity and higher propensity to 
metastasize [15]. Furthermore, many chemotherapeutic agents are not able to penetrate 
into the hypoxic zones that are located at a distance from the blood vessels, decreasing 
the efficiency of chemotherapy [16]. 
 
 
5 
 
Figure 1.2 Tumor chronic and acute hypoxia. Blood vessels in malignant solid tumors 
are chaotic, highly tortuous, often far apart, and have sluggish blood flow. Chronic 
hypoxia results from an increase in diffusion distances with tumor expansion and acute 
hypoxia is the result of the temporary closure or reduced flow in certain vessels. 
 
Hypoxia arises as a result of an imbalance between the supply and consumption 
of oxygen. Major causative factors of tumor hypoxia are abnormal vasculature, vascular 
insufficiency, treatment or malignancy related anemia and increasing oxygen demands 
for tumor growth [17]. Tumor hypoxia can be grouped into two distinct categories (Fig. 
1.2) [18]. Chronic (diffusion-related) hypoxia is caused primarily by an insufficient 
number of blood vessels and the oxygen supply to these cells is limited by diffusion 
distance of oxygen through tissue that is respiring. Acute (perfusion-related) hypoxia 
results from the temporary closing of a tumor blood vessel owing to the malformed 
vasculature of the tumor. An important aspect of hypoxia in tumors is that it tends to be 
very heterogeneous with some regions of a tumor showing low levels of hypoxia whereas 
other regions demonstrate much higher levels [19].  
Tumor microenvironments such as tumor oxygenation, vasculature and blood 
supply (flow) are key factors for radiation treatment outcomes and prognoses in patients 
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with head and neck cancer. Given the biological problems associated with tumor 
oxygenation and blood flow, the goal for clinicians has been to identify poor prognosis 
tumors for differential treatment strategies. Measurement of tumor hemodynamics may 
serve as a predictive tool allowing treatment selection based on biologic tumor 
characteristics. Ultimately, reduction of side effects in patients not benefiting from 
radiation treatment will be feasible. 
1.5 Techniques and Findings in Hemodynamic Measurements of HNSCC 
The “gold standard” for detecting and characterizing of tumor hypoxia is the use 
of invasive electrodes. The oxygen measurements involve inserting an electrode into a 
tumor or metastatic lymph node and measuring oxygen from several points per needle 
track in sub-millimeter steps. Each probe is reported to sample a tissue volume of about 
50–100 cells. Typically, more than a hundred measurements are generated over the 
accessible areas of the lesion, providing a composite overview of the lesion's hypoxia 
status. Previous oxygen electrode studies have shown that tumor hypoxia is an adverse 
prognostic factor in HNSCC [20-29]. However, this invasive method measures only a 
tiny spot of tissue, making repeated measurements extremely difficult and often 
producing inconsistent results in highly heterogeneous tumor tissues. 
Immunohistochemical staining of tumor biopsy samples results in high-resolution 
images that can be analyzed for several endogenous and exogenous markers of interest. 
For example, pimonidazole is a hypoxia-specific marker. It is administered intravenously 
prior to biopsy. High pimonidazole staining indicates a high level of tumor hypoxia and 
is prognostic for poor clinical outcome in HNSCC [30]. As another example, HIF-1α 
protein only exists in the hypoxic condition and is rapidly degraded by ubiquitination 
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under normoxia. In most studies, HIF-1α overexpression is associated with poor 
outcomes response to the treatment [31]. Therefore, HIF-1α is thought to be an 
endogenous hypoxic marker and a prognostic predictor for the HNSCC. Unfortunately, 
the tumor biopsy samples are often small and represent only a fraction of the entire 
tumor. Furthermore, exogenous markers require intravenous administration before biopsy 
samples can be taken. Finally, the acquisition of a tumor biopsy often requires the use of 
general anesthesia, and this procedure is not attractive for repetitive measurements. 
PET imaging using 18F-fluoromisonidazole (18F-FMISO) can be used to  
quantify tissue hypoxia. Tumor to muscle ratio of 18F-FMISO has been found to be 
significantly correlated with tumor hypoxic fraction as measured by the polarographic 
electrode in head and neck cancer patients [32, 33]. Importantly, the level of hypoxia 
depicted by 18F-FMISO PET before treatment was found to be correlated with local-
regional failure. Other studies demonstrated that PET imaging of hypoxia with 18F-
FMISO after one or two weeks of radiotherapy was correlated better with treatment 
outcomes than imaging before treatment [34-36]. 15O-labeled water (15O-H2O) PET has 
also been used for imaging of blood perfusion in patients with head and neck cancer [37]. 
Preliminary results indicated an association between tumor perfusions and radiation 
treatment outcomes. However, PET involves the peripheral injection of invasive 
radiotracers. Other limitations of PET techniques include limited ability of tracers to 
freely access the tumor cells and their half-life in the circulation and tumor relative to the 
radiological half-life of the PET isotope used.  
Diffusion-weighted magnetic resonance imaging (DWI) is a form of MR imaging 
based upon measuring the random Brownian motion of water protons within a voxel of 
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biologic tissue. One recent study showed a significantly lower pretreatment apparent 
diffusion coefficient (ADC) in lymph node metastases in complete responders than in 
partial responders [38]. Monitoring of response to radiation therapy is the area where 
DWI has the potential to make large impact on clinical managements. Early results 
suggest that cancers that showed only a small increase or decrease in ADC during 
treatment or in the early post-treatment phase are more likely to fail treatment [38-43] 
and more interestingly, change in the ADC during therapy served as a better predictor 
than baseline ADC alone [41, 42].  
T1-weighted Dynamic Contrast-Enhanced MRI (DCE-MRI) is used to estimate 
the flow, volume, and permeability of blood vessels in tumors. DCE-MRI has the 
advantage that the whole tumor and lymph nodes can be analyzed voxel by voxel. Some 
pilot studies using DCE-MRI in HNSCC found that a measure of hypoxia correlated 
positively with the kinetic transport constant, Ktrans and hypoxia correlated negatively 
with tumor blood flow [44, 45]. Tumors with large areas of lower blood volume (BV) or 
impaired tumor perfusion were associated with local treatment failure [46]. Some studies 
found low pretreatment Ktrans in regional lymph node metastases was associated with a 
poor response to concurrent chemo-radiation therapy [47, 48]. Heterogeneity of 
microvascular parameters has been demonstrated by DCE-MRI using voxel-by-voxel 
analysis. One study showed that skewness of pretreatment Ktrans was the strongest 
prognostic factor for outcome following chemo-radiation therapy [49].  
Other MRI technologies have been developed to measure tissue perfusion. 
Arterial spin labeling (ASL) is a MR perfusion technique that uses intra-arterial water as 
an endogenous tracer and hence does not require administration of intravenous 
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gadolinium. It has been widely applied for brain tumors, but there are only a few reports 
regarding the use of ASL-MRI for patients with HNSCC. Blood oxygenation level 
dependent (BOLD) MRI is generally a more sensitive measure of oxygen levels for 
perfusion-related hypoxia than for diffusion-dependent hypoxia [50]. This technique is 
still under development in patients with head and neck cancers, and further research is 
warranted. 
Dynamic Contrast-Enhanced CT (DCE-CT) uses the same principles as DCE-
MRI. In DCE-CT, iodinated contrast agents absorb electromagnetic energy via the 
photoelectric effect, directly attenuating the x-ray beam. The advantage of DCE-CT is the 
linear relationship between contrast concentration and attenuation in CT, which facilitates 
quantitative (versus relative) measurement of blood flow and blood volume. The 
disadvantages of DCE-CT include the limited coverage, and the use of ionizing radiation 
and iodinated contrast agents. In a DCE-CT study of 105 patients with HNSCC treated by 
radiotherapy or chemo-radiotherapy with mean follow-up of 2.2 years, patients with a 
lower pretreatment perfusion rate had a higher local failure rate [51]. However, in another 
study, DCE-CT parameters did not correlate with the hypoxic areas [51]. So the ability of 
DCE-CT parameters to reflect tissue hypoxia in HNSCC is still unclear. 
1.6 Near-infrared Diffuse Optical Spectroscopy (DOS) for Tissue Oxygenation 
Measurements 
Diffuse optical spectroscopy (DOS) utilizes light in the near infrared (NIR) 
spectral range to quantify the biochemical state of tissues through the measurement of the 
absorption and scattering properties of tissues. The NIR window defines the range of 
wavelengths from 650 to 900 nm where absorption is relatively low and light has its 
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maximum depth of penetration up to several centimeters in tissue. Within the NIR 
window, scattering is the most dominant light-tissue interaction, and therefore the 
propagating light becomes diffused rapidly. In biological tissue, the primary absorbers of 
near-infrared light are deoxygenated hemoglobin, oxygenated hemoglobin, water, and 
lipids, and the major source of scattering is the refractive index mismatch between cell 
organelles like mitochondria and cytoplasm, and extracellular media and tissue structural 
components such as collagen and elastin fibers. When using NIR spectroscopy to detect 
optical properties of deep tissues, a pair of source and detector fibers is usually placed 
along the tissue surface with a distance of a few millimeters to centimeters. NIR light 
generated by a laser emits into tissues through the source fiber and is detected by a 
photodetector through the detector fiber. The penetration depth of NIR light in biological 
tissues is approximately half of the source-detector (S-D) separation.  
The probabilities of absorption and scattering are described by an absorption 
coefficient, μa, and a reduced scattering coefficient, μs’, which are also referred to as 
optical properties, intrinsic to the probed tissue volume [52, 53]. Changes in 
physiological parameters such as tissue oxygenation can be calculated based on tissue 
optical properties measured at different wavelengths [54]. Light absorption in tissue is 
dependent on the absorption spectra of the major tissue chromophores (Fig. 1.3). In the 
NIR region, oxygenated hemoglobin (HbO2) and deoxygenated hemoglobin (Hb) are the 
dominant chromophores affecting absorption. Simultaneous measurements at multiple 
wavelengths allow to measure the concentrations of oxygenated and deoxygenated 
hemoglobin ([HbO2] and [Hb]), total hemoglobin concentration (THC = [HbO2] + [Hb]), 
and oxygen saturation (StO2 = [HbO2]/THC). 
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Figure 1.3 Absorption spectra of three dominant near-infrared chromophores in tissues, 
namely oxygenated-hemoglobin (HbO2), deoxygenated-hemoglobin (Hb), and water 
(H2O). The concentrations of Hb and HbO2 are assumed to be 50 μM, a typical value for 
blood-perfused tissues. Extinction coefficients for Hb and HbO2 are obtained from [55]. 
Within the NIR spectral window (650 to 900 nm), light can penetrate tissues deeply due 
to the relatively low tissue absorption. 
 
 
Figure 1.4 Three types of DOS systems including frequency‐domain (FD), time-resolved 
(TR), and continuous wave (CW).  
 
DOS devices can be categorized as time-resolved (TR), frequency-domain (FD), 
and continuous-wave (CW) systems based on the types of light sources employed (Fig. 
1.4) [54]. In TR systems, a very short NIR pulse, usually on the order of picoseconds, is 
introduced into the medium, and the delay and spread of the transmitted pulse is 
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measured. Because of the need for high-speed detection and high-speed emitters, time-
resolved methods are the most expensive and technically complicated method. The FD 
systems use amplitude-modulated light at radio-frequency range (e.g. 110 MHz) to 
produce a diffusive wave within the medium and the amplitude and phase of the 
transmitted diffuse light wave are measured. The TR and FD systems can separate 
absorption and scattering effects thus, yielding absolute values of [Hb] and [HbO2]. CW 
systems use constant amplitude sources and measure the attenuated light amplitude as a 
function of S-D separation and wavelength. CW systems are generally less expensive 
than TR and FD systems and provide rapid data collection. However, they lack the 
capability of characterizing simultaneously the absorption and scattering coefficients. As 
such, CW systems usually assume constant μs’ and provide only information about μa.  
1.7 Near-infrared Diffuse Correlation Spectroscopy (DCS) for Tissue Blood Flow 
Measurements 
DCS [53, 56-58] or diffusing-wave spectroscopy (DWS) [59-63] is an emerging 
optical technique that utilizes coherent near-infrared light to non-invasively measure 
tissue blood flow. DCS uses a NIR laser with long coherence length (> 5 meters) as the 
light source and a single-photon-counting avalanche photodiode (APD) as the detector. 
Similar to DOS, the source and detector fibers connected to the laser and APD were 
placed on the tissue surface with certain distance (i.e., S-D separation). The light intensity 
interference pattern (i.e., speckle pattern) on the tissue surface is detected, which depends 
on the motion of moving scatterers in the tissue measured (primarily red blood cells in 
microvasculature). By quantifying the changes in speckle pattern, blood flow index (BFI) 
can be extracted. 
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DCS measurements of deep tissue blood flow have been validated in various 
organs and tissues against other standards, including Doppler ultrasound [64-67], Xenon-
CT [68], laser Doppler flowmetry (LDF) [52, 69], fluorescent microsphere flow 
measurement [66, 70], and ASL-MRI [71, 72], or through comparisons to literatures [56, 
58, 73-75]. The probing depth of NIR DCS (several centimeters) is significantly larger 
than those (several millimeters) of similar optical modalities such as LDF [76-78], 
Doppler optical coherence tomography (DOCT) [79], and optical micro-angiography 
(OMAG) [80]. DCS is primarily sensitive to microvasculature rather than large blood 
vessels (e.g., Doppler ultrasound measurement), and does not require radiation exposure. 
Systems based on DCS are portable and relatively inexpensive, allowing for bedside 
monitoring with short acquisition time (varying from 6.5 ms to several seconds) [74, 81-
83]. Due to these features, usages of DCS expand continuously into new applications in 
various deep organs/tissues such as muscle [72, 82, 84-87], tumor [64, 65, 83, 88-92] and 
brain [52, 58, 59, 66-68, 70, 71, 73, 74, 81, 93-97]. 
1.8 Current Study Limitations 
In summary, studies in cancers including head and neck carcinoma have exhibited 
an increase of positive response to radiotherapy in tumors with high pretreatment 
oxygenation compared to poorly oxygenated tumors [98, 99]. However, in these studies 
some well-oxygenated tumors failed to respond, while some hypoxic tumors responded 
well, possibly due to changes in tumor oxygenation during radiation therapy. Factors that 
modulate tumor oxygenation include blood flow, blood oxygenation, and tumor oxygen 
metabolism [18]. Recent PET, MRI and CT investigations have demonstrated significant 
tumor blood flow and oxygenation changes during the period of therapy and have 
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suggested that these early blood flow variations may have unique prognostic value [34-
36, 41, 42, 100-102]. Moreover, tumor blood flow level may impact chemotherapy 
efficacy since chemo-drug delivery depends on tumor blood flow.  
Acute hemodynamic and metabolic changes during radiation delivery may also 
affect treatment efficacy since radiation causes acute damage in tumor vasculatures 
which may immediately impair blood oxygen supply to the tumor. To exert its sensitizing 
effect, oxygen must be present during or within milliseconds after the radiation exposure 
delivery of the radiation dose [12]. Moreover, oxygen must also be present in sufficient 
quantities to have a radio-sensitizing effect. For example, below a partial pressure of 20 
mmHg, cells have significant protection from radiation damage [103]. However, there 
have been no reports of monitoring tumor hemodynamics and metabolism during 
radiation delivery. 
Although many techniques have been used for tumor hemodynamic 
measurements, none of them are perfect as reviewed earlier. Near-infrared diffuse optical 
instruments provide noninvasive, rapid, portable, and low-cost alternatives for evaluation 
of deep tissue hemodynamic parameters. Integration of traditional DOS and DCS into the 
same instrumentation creates a new opportunity to make comprehensive assessment of 
multiple parameters in the tumor microenvironment including tumor blood flow and 
oxygenation. The goal of this study is to adapt and improve some novel diffuse optical 
techniques developed in our laboratory for longitudinal evaluation of tumor 
hemodynamic responses throughout the time course of treatment (including during 
radiation delivery) and to investigate the predictive ability of multiple hemodynamic 
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parameters in early prediction of radiation treatment outcomes. Ultimately, such 
information will enable clinicians to optimize individual cancer therapies. 
1.9 Thesis Organization 
This thesis is organized with the following chapters. Chapter 2 introduces the 
theory and instrumentation of DOS and DCS technologies. Chapter 3 describes a study 
to optimize BFI extraction methods through simultaneously fitting multiple parameters 
from one single autocorrelation function in DCS. Chapter 4 presents a study to adapting 
a novel DCS flow-oximeter for noninvasive monitoring of tumor hemodynamic changes 
during radiation delivery. Chapter 5 reports the continual monitoring of tumor blood 
flow and oxygenation over 7 weeks of chemo-radiation therapy using the hybrid 
DOS/DCS technique and investigates the prognostic values of hemodynamic 
measurements for early predicting treatment responses to radiotherapy. Finally, Chapter 
6 summarizes the contributions of this thesis, and discusses the limitations and future 
research directions. 
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CHAPTER 2 THEORY AND INSTRUMENTATION OF DIFFUSE OPTICAL 
TECHNOLOGIES  
Several NIR diffuse optical instruments have been recently developed in our 
laboratory and used in the studies covered by this dissertation, including a hybrid 
DOS/DCS device and a dual-wavelength DCS flow-oximeter. The hybrid device 
combining a commercial FD tissue-oximeter (Imagent, ISS, IL, USA) and a custom-built 
CW DCS flowmeter allows us to simultaneously measure tumor blood flow and blood 
oxygenation [85]. The CW dual-wavelength DCS flow-oximeter can detect the relative 
changes of tumor blood flow and blood oxygenation. The dimension/cost of the DCS 
flow-oximeter is much smaller/lower than the hybrid DOS/DCS instrument.  
2.1 FD and CW DOS Tissue Oximetry 
2.1.1 FD Tissue Oximetry 
Frequency-domain DOS techniques employ intensity modulated light and 
quantify the absorption (μa) and reduced scattering (μs’) coefficients through measuring 
the phase shift and amplitude after the diffusive photons propagate through the medium. 
The propagation of NIR light in high scattering media such as biological tissues can be 
quantified by photon diffusion equation [Appendix I, Eq (2A.10)]. In frequency domain, 
analytical solutions of amplitude reduction (Φac) and phase shift (φ) of the detected light 
when using an isotropic point source in a semi-infinite homogeneous medium are given 
in Appendix I [Eq (2A.22) – Eq (2A.23)], which can be rewritten as linear combinations 
of Φac, φ and S-D distance (ρ) [Appendix I, Eq (2A.25) – Eq (2A.26)]. Thus, fitting the 
slopes of ln (ρ
2
 Φac) and φ as a function of ρ (Sac and Sφ respectively) can generate µa and 
µs’ (see Eq (2.1) to Eq (2.4)). 
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 Sac = −(
vμa
2D
)
1 2⁄
[(1 + x2)1 2⁄ + 1]
1 2⁄
 (2.1)  
 Sφ = (
vμa
2D
)
1 2⁄
[(1 + x2)1 2⁄ − 1]
1 2⁄
 (2.2)  
Here, light source is modulated at a frequency (ω/2π), v is the speed of light in the 
medium, D = v/[3(μa+μs’)] is called photon diffusion constant and x is defined as ω/vμa. 
Therefore, the values of μa and μs’ can be extracted from the (Sac, Sφ) using the following 
equations [104]: 
 μa =
ω
2v
(
Sφ
Sac
−
Sac
Sφ
) (2.3)  
 μs
, =
v(Sφ
2 − Sac
2)
3μa
− μa (2.4)  
The tissue absorption depends linearly on the concentrations of tissue 
chromophores (primarily HbO2 and Hb). In particular, the absorption coefficient µa at 
wavelength λ is given by 
 μa(λ) = ∑ 𝑖(𝜆)𝑐𝑖𝑖  (2.5)  
Here εi(λ) is the wavelength-dependent extinction coefficient and ci the 
concentration of the ith chromophore. Generally, the extinction spectra εi(λ) is known for 
typical tissue chromophores and thus the unknown chromophore concentrations ci can be 
determined by measuring μa at multiple optical wavelengths.  
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Figure 2.1 Extinction coefficients for oxygenated hemoglobin (HbO2) and deoxygenated 
hemoglobin (Hb) for near-infrared wavelengths 
 
Frequency-domain DOS diffusion approximation enables us to separate the 
scattering and absorption contributions in the detected light signals and to determine the 
absolute μa and μs’ at each wavelength. The measured values of μa at two wavelengths 
translate Eq (2.5) into a linear system of two equations (one per each wavelength) with 
two unknowns ([HbO2] and [Hb]). The solutions in turn give total hemoglobin 
concentration (THC = [HbO2] + [Hb]) and blood oxygen saturation (StO2 = 
[HbO2]/THC). The two wavelengths λ1 and λ2 for near-infrared oximetry are usually 
chosen such that λ1 < λiso < λ2, where λiso (800 nm) is the isosbestic wavelength at which 
the extinction coefficients of oxygenated- and deoxygenated-hemoglobin intersect (see 
Fig 2.1). 
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2.1.2 CW Tissue Oximetry 
CW devices are simpler, faster, less expensive and more compact than FD devices. 
However, CW DOS is not inherently able to separate absorption and scattering effects 
[105]. Under the assumption that the μs’ remains constant, modified Beer-Lambert law 
can be employed to measure relative changes in hemoglobin concentrations (Δ[HbO2] 
and Δ[Hb]):  
 ∆𝑂𝐷(𝜆) = − ln
𝐼
𝐼0
= ∑∆μ𝑎𝑖(𝜆)
𝑖
𝜌𝐷𝑃𝐹(𝜆) =∑ɛ𝑖(𝜆)∆𝑐𝑖
𝑖
𝜌𝐷𝑃𝐹(𝜆) (2.6)  
Here OD is the optical density of the medium, I0 and I are the measured intensities 
before and after the concentration change, ci is the concentration of the ith chromophore, 
ρ is the source-detector distance, and DPF is the differential pathlength factor. 
Considering the change in ∆µa resulting from the changes in [HbO2] and [Hb], Eq (2.6) 
can be rewritten as: 
 ΔOD(λ) =(εHbO2(λ)Δ[HbO2] +  εHb(λ)Δ[Hb])𝜌𝐷𝑃𝐹(𝜆)  (2.7)  
By measuring ΔOD at two wavelengths and using the known extinction 
coefficients of HbO2 and Hb at two wavelengths (λ1 and λ2), we can then determine 
relative changes of [HbO2] and [Hb]. 
 ∆[𝐻𝑏] =  
ɛ𝐻𝑏𝑂2
𝜆2 ∆𝑂𝐷
𝜆1
𝐷𝑃𝐹𝜆1
− ɛ𝐻𝑏𝑂2
𝜆1 ∆𝑂𝐷
𝜆2
𝐷𝑃𝐹𝜆2
(ɛ𝐻𝑏
𝜆1 ɛ𝐻𝑏𝑂2
𝜆2 − ɛ𝐻𝑏
𝜆2 ɛ𝐻𝑏𝑂2
𝜆1 )𝜌
 (2.8)  
 ∆[𝐻𝑏𝑂2] =  
ɛ𝐻𝑏
𝜆1 ∆𝑂𝐷
𝜆2
𝐷𝑃𝐹𝜆2
− ɛ𝐻𝑏
𝜆2 ∆𝑂𝐷
𝜆1
𝐷𝑃𝐹𝜆1
(ɛ𝐻𝑏
𝜆1 ɛ𝐻𝑏𝑂2
𝜆2 − ɛ𝐻𝑏
𝜆2 ɛ𝐻𝑏𝑂2
𝜆1 )𝜌
 (2.9)  
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DPF can be obtained from the literature, or calculated from baseline μs’ and μa 
values measured by FD devices (see Appendix III). 
2.2 Diffuse Correlation Spectroscopy (DCS) 
DCS uses coherent NIR light to penetrate deep tissues and measures speckle 
fluctuations of the diffuse light. Most photons scatter multiple times before detection at 
some distance from the light source. Each scattering event causes a random scattering 
phase shift in the electric field of light and the superposition of multiple light fields with 
different phases creates a speckle pattern of interference at the detector. If the scattering 
particles move, the speckle pattern fluctuates in time. These fluctuations of the electric 
field and intensity carry the dynamical information about the motion of moving 
scatterers. In biological tissues, the primary moving scatterers are red blood cells. By 
characterizing the fluctuations in speckle intensity over time, we gather information about 
blood flow in tissue. Briefly, time dependent light intensity fluctuation can be quantified 
by the temporal autocorrelation function. The electric field autocorrelation function is 
related to the measured light intensity autocorrelation function through Siegert relation 
[106]. It has been found that the electric field autocorrelation function 𝐺1is governed by a 
correlation diffusion equation [56, 57], and blood flow index (BFI) in biological tissues 
can be calculated by fitting the measured autocorrelation function curve with the solution 
of correlation diffusion equation. 
The unnormalized electric field temporal autocorrelation function,  𝐺1(𝑟, 𝜏) =
〈?⃗?∗(𝑟, 𝑡) · ?⃗?(𝑟, 𝑡 + 𝜏)〉 obeys the correlation diffusion equation [56, 57] [Eq (2A.29) in 
Appendix II]. For the simple case of a CW point source in a semi-infinite homogeneous 
medium, the solution can be obtained as [Eq (2A.32) in Appendix II]: 
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 𝐺1(𝜌, 𝜏) =
vS0
4𝜋𝐷
(
e−𝐾(𝜏)𝑟1
𝑟1
−
e−𝐾(𝜏)𝑟2
𝑟2
) (2.10)  
Here,  𝜌  is the source-detector separation, r1 = √ρ2 + z02 , and 
r2 = √ρ2 + (z0 + 2zb)2. 𝐾(𝜏) = √
𝑣
𝐷
(μa +
𝛼
3
μ𝑠′𝑘0
2〈∆𝑟2(𝜏)〉) . Scatterers in tissue may 
be static (e.g., organelle) or dynamic (moving red blood cells). Therefore, a parameter α 
is added to account for not all scatterers being dynamic and is defined as the ratio of 
moving scatterers to total scatterers. k0 = 2π/λ is the wavenumber of the CW light in the 
medium. 〈∆𝑟2(𝜏)〉 is the mean square displacement of a scatterer duing the delay time τ. 
z0 ≈ 1/ µs’ and 𝑧𝑏 =
2
3μs
1+𝑅𝑒𝑓𝑓
1−𝑅𝑒𝑓𝑓
  , where Reff is the effective reflection coefficient to 
account for the index mismatch between tissue and air: Reff = -1.44n
-2 
+ 0.71n
-1 
+ 0.668 + 
0.064n, and n is the ratio of refraction indices of tissue and air n = ntissue/nair ≃ 1.33. We 
get the normalized electric field temporal autocorrelation function from G1: 
 𝑔1(𝜌, 𝜏) =
𝐺1(𝜌, 𝜏)
𝐺1(𝜌, 0)
= (
e−𝐾(𝜏)𝑟1
𝑟1
−
e−𝐾(𝜏)𝑟2
𝑟2
) (
e−𝐾(0)𝑟1
𝑟1
−
e−𝐾(0)𝑟2
𝑟2
)⁄  (2.11)  
In practice, DCS measures the normalized intensity temporal auto-correlation 
function, 𝑔2(𝑟, 𝜏) = 〈I(t) ∙ I(𝑡 + 𝜏)〉 〈I(𝑡)〉
2⁄ , with the intensity I(t) = |E(t)|2. 𝑔2(𝑟, 𝜏) is 
then related to the normalized electric field temporal autocorrelation function, g1(τ), 
through the Siegert relation [106],  
 g2(τ ) = 1 + β|g1(τ )|
2
 (2.12)  
β is a constant determined primarily by the collection optics of the experiment, 
and is equal to one for an ideal experiment setup. The expression of 𝐾(𝜏) suggests that 
the decay of the autocorrelation function depends on tissue optical properties µa and µs’, 
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the mean-square-displacement of the moving scatterers, 〈∆𝑟2(𝜏)〉, and the unitless factor 
α. In biological tissues, for the case of diffusive motion,〈∆𝑟2(𝜏)〉 = 6𝐷𝐵𝜏, where DB is 
the effective Brownian diffusion coefficient of the moving scatterers and is distinct from 
the well-known thermal Brownian diffusion. 
Substituting 〈∆r2(τ)〉 = 6DBτ into K(τ), we get K(τ) = √
v
D
(μa + 2αDBμs
′k0
2τ), 
which suggests that the decay of the autocorrelation function depends on µa, µs’, and 
αDB . From our previous description, αDB  carries information about the dynamic 
properties of moving red blood cells in the microvasculature and is defined as a blood 
flow index (BFI).  
Usually, BFI calculations begin with using the Siegert relationto first determine 
the β. Using the g2 data at earliest τ and letting g1 ≈ 1 (i.e.,       10,rG/0,rG0,rg 111 

) lead 
to 1)0,r(g2 

. Using DCS measured ),r(g2 

, calculated β and Siegert relation, 
),r(g1 

 is calculated for all τ. Eq (2.11) is then used with the unknown parameter αDB 
(flow index) to fit the g1 derived from DCS measurements. Although the unit of 𝛼𝐷𝐵 
(cm
2
/s) is different from the traditional blood perfusion unit [ml/min/100 g], relative 
changes in this blood flow index (𝑟𝐵𝐹 = 𝐵𝐹𝐼/𝐵𝐹𝐼0) have been found to correlate quite 
well with other blood flow measurement modalities [65, 66, 68, 69, 72] , where 𝐵𝐹𝐼0 is 
the baseline flow value measured before the physiological change. 
 
 
23 
2.3 DOS/DCS Instruments 
2.3.1 FD Tissue Oximeter 
In this study a commercial NIR frequency-domain oximeter (Imagent, ISS, IL, 
USA) was used which has two channels, each with four sets of four laser sources emitting 
light at one of four wavelengths (690, 750, 780 and 830 nm). The four light sources in 
each set emit light into tissue through optical fibers placed at four progressively increased 
distances (2.0, 2.5, 3.0, and 3.5 cm) from a large fiber bundle (core diameter = 2.5 mm) 
connected to a photomultiplier tube (PMT) detector operated in the heterodyne mode. 
The lasers are rapidly multiplexed (10 ms) in sequence to allow only one source on at any 
point in time. A frequency of 110 MHz is used to modulate the intensity of the light 
sources, and a dynode driver at 110.005000 MHz is used to generate a 5-kHz output 
signal for phase and intensity measurement. Typically, the measurement time for each 
cycle covering all source-detector pairs and wavelengths is 150 ms. Data from several 
cycles can be averaged to improve signal-to-noise ratio (SNR) when high sampling rate is 
not necessary. 
The Imagent uses a heterodyne detection circuit [107, 108] to down-convert the 
radio frequency from the 110 MHz signal to the 5 kHz, while retaining the amplitude and 
phase information of the detected wave. This low-frequency signal is easily processed by 
standard electronic digitization methods. Heterodyne detection allows more accurate 
phase and amplitude measurements than homodyne techniques performing amplitude and 
phase measurements without down-converting the radio frequency. The Imagent 
provides >10 times higher signal-to-noise ratio than the homodyne detection previously 
used in hybrid systems developed [92, 109, 110].  
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2.3.2 DCS Flowmeter 
A DCS flowmeter consists of a CW long-coherence (> 5 m) laser at 785 nm (100 
mw, CrystaLaser Inc., NV, USA), 4 single-photon-counting avalanche photodiodes 
(APDs) (e.g., Perkin Elmer Inc., Canada), and an autocorrelator board (Correlator.com, 
NJ, USA). A fiber-optic probe is usually made using source and detector fibers confined 
by a custom-designed soft foam pad. The laser diode delivers light to the tissue through a 
multimode source fiber (diameter = 200 µm). One to four single-mode fibers (diameter = 
5 µm) connected to the APDs are used to collect speckle intensity variation from a single 
(or a few) speckle(s) on the tissue surface. The transistor-transistor logic (TTL) pulses 
output from the APD are fed into a correlator board for computing the light intensity [i.e., 
photon count rate with a unit of kilo counts per second (kcps)] and intensity temporal 
autocorrelation function [56, 57]. The blood flow index is then extracted from the 
autocorrelation function using custom-designed software. 
 
Figure 2.2 A diagram of the multi-tau photon correlator structure 
 
The autocorrelator is based on a multi-tau scheme with a multiple tier structure of 
registers to reduce the computational load (Fig. 2.2). The first tier has 32 registers, and 
higher tiers have 16 registers each. The first 32 registers of the first tier have a bin width 
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T0 (typically 160 ns) and the bin width doubles every 16 registers of the following tiers. 
When a measurement starts, the incoming photon count (the number of TTL pulses) 
updates the first register within each binning time T0, and the value in each register is 
passed to its right as a new value is coming in from the left. From the second tier, the first 
register value of nth tier is constructed by sum of the last two register values in (n−1)th 
tier, which means the registers of n’th tier is updated every 2
n−1
T0. Therefore, each 
register updates with the corresponding bin width of the register. For each shift that 
occurs in the register, the unnormalized intensity autocorrelation coefficient for the ith 
register, G2(τi), is calculated as the average value of ni⋅n0, where ni indicates the photon 
count in the ith register, n0 is the photon count at zero delay time with the same bin width 
as the ith register, and τi is the delay time between ni and n0. Note that n0 is the photon 
count in the first register when ni is in the first tier, while n0 is the summation of the 
photon count in the first four registers when ni is in the third tier (T/T0=4), etc. With a few 
hundred register channels (512 channels for a 31 tier system, for example), a delay time 
that ranges from hundreds of nanoseconds to minutes can be achieved, and the 
computation load is greatly reduced compared to a linear autocorrelator. 
2.3.3 Hybrid DOS/DCS  
Previously, Dr. Arjun Yodh’s group at the University of Pennsylvania combined a 
custom-made homodyne FD DOS instrument with a DCS device for simultaneous 
measurements of tissue blood flow and oxygenation. However, the homodyne instrument 
has a relatively low signal-to-noise level and large crosstalk between the detected 
amplitude and phase [92, 109, 110]. Our group has initially attempted to combine a 
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heterodyne FD Imagent (ISS Inc.) and DCS device to improve the SNRs of tissue 
hemodynamic measurements [85, 111]. 
 
Figure 2.3 Schematic of hybrid Imagent/DCS instrument for simultaneously measuring 
tumor oxygenation and blood flow: (a) hybrid instrument and (b) fiber-optic probe 
 
Figure 2.3 shows the picture and diagram of our hybrid Imagent/DCS instrument. 
Computer-controlled TTL signals were used to control the Imagent and DCS devices 
working sequentially. A 50 ms delay between the transition of Imagent and DCS 
measurements was set to avoid the potential cross-measurement interference. The design 
of the hybrid fiber-optic probe was based on the commercial Imagent probe. DCS source 
and detector fibers were housed inside the Imagent probe. The optical fibers for the DCS 
measurement were arranged in a particular pattern for reducing the interference between 
DCS and DOS measurements. Using this hybrid system, we have successfully quantified 
blood flow and blood oxygenation in the brain [112], skeletal muscles [85, 113-115], and 
head and neck tumors [116]. Since then, several other groups have also built similar 
hybrid Imagent/DCS systems for their studies [67, 117, 118]. 
 
 
27 
2.3.4 Dual-Wavelength DCS Flow-Oximeter 
Although the hybrid DCS/DCS systems can effectively quantify both tumor blood 
flow and oxygenation, it is relatively expensive, large, and complicated to build and 
operate. A portable dual-wavelength CW DCS flow-oximeter was recently developed in 
our laboratory, which can simultaneously measure the relative changes in tumor blood 
flow and oxygenation from the same region of tissues [85].  
 
Figure 2.4 A diagram of the dual-wavelength DCS Flow-oximeter 
Figure 2.4 shows a dual-wavelength 4-channel DCS flow-oximeter. Basically, we 
added another long-coherence CW laser at 854 nm to the previous single-wavelength 
(785 nm) DCS system. The two lasers were switched on and off alternately by TTL 
signals controlled automatically through a custom DCS control panel program. Similarly 
to CW DOS, we can extract relative changes of tissue blood oxygenation (i.e., Δ[HbO2], 
Δ[Hb], ΔTHC) via measuring light intensity changes at the two wavelengths. The dual-
wavelength DCS flow-oximeter used two source fibers (core diameter of each fiber = 200 
µm, emission area = 0.13 mm
2
) that were bundled tightly together. The S-D separation 
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was set to 2.5 cm for tumor hemodynamic measurement. DCS flow-oximeter shared the 
same source and detector fibers for both blood flow and oxygenation measurements, thus 
making its probe smaller and easier to be installed on the patients than the hybrid 
Imagent/DCS probe.  
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Appendix I: Semi-infinite Solution of Photon Diffusion Equation in Frequency 
Domain  
2.AI.1 Photon Diffusion Equation 
Photon transport in biological tissue can be modeled by the radiative transfer 
equation (RTE) [119], 
 
1
v
𝜕𝐿(𝑟, ?̂?, 𝑡)
𝜕𝑡
+ ?̂? ∙ ∇𝐿(𝑟, ?̂?, 𝑡) 
= −μ𝑡𝐿(𝑟, ?̂?, 𝑡) + μ𝑠 ∫ 𝐿(𝑟, ?̂?
′, 𝑡)𝑓(?̂?, ?̂?′)𝑑
4𝜋
?̂?′ + 𝑄(𝑟, ?̂?, 𝑡) . 
(2A.1)  
The light radiance 𝐿(𝑟, ?̂?′, 𝑡) is defined as the light power per unit area traveling in the 
?̂? direction at position 𝑟 and time t and has units W/(m2 sr). 𝑄(𝑟, ?̂?, 𝑡) (W/(m3 sr)) is the 
power per volume emitted by sources at position 𝑟 and time t in the ?̂? direction. 𝑓(?̂?, ?̂?′) 
is the normalized scattering phase function indicating the probability of scattering a 
photon that travels along direction Ω̂  into the direction  Ω̂′ , and it satisfies 
∫ 𝑓(?̂?, ?̂?′)𝑑
4𝜋
?̂?′  = 1. The loss of radiance out of each infinitesimal volume element 
depends on the transport coefficient μt = μa + μs. Here, the light scattering and absorption 
coefficients, µs and µa, are the inverses of the mean free paths for scattering and 
absorption, respectively. v is the speed of light in the medium. 
A standard approximation method for the RTE is the PN approximation. In this 
method, 𝐿(𝑟, ?̂?′, 𝑡)  in Eq. (2A.1) is  written as a series expansion of spherical harmonics 
up to Nth order [120]: 
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 𝐿(𝑟, ?̂?, 𝑡) ≈ ∑ ∑ 𝐿𝑙𝑚(𝑟, 𝑡)𝑌𝑙𝑚(?̂?)
𝑙
𝑚=−𝑙
𝑁
𝑙=0 . (2A.2)  
In diffusion theory, radiance is taken to be largely isotropic and the P1 
approximation is valid, so only the isotropic and first-order anisotropic terms are 
used[121-124]: 
 𝐿(𝑟, ?̂?, 𝑡) ≈ ∑ ∑ 𝐿𝑙𝑚(𝑟, 𝑡)𝑌𝑙𝑚(?̂?)
𝑙
𝑚=−𝑙
1
𝑙=0
=
1
4𝜋
𝛷(𝑟, 𝑡) +
3
4𝜋
𝐽(𝑟, 𝑡) ∙ ?̂? (2A.3)  
Here, 𝛷(𝑟, 𝑡) ≡ ∫ 𝐿(𝑟, ?̂?, 𝑡)𝑑
4𝜋
?̂?  is the photon fluence rate, and 
𝐽(𝑟, 𝑡) ≡  ∫ 𝐿(𝑟, ?̂?, 𝑡)?̂?𝑑
4𝜋
?̂? is the photon flux. Similarly the photon source can be 
written as: 
 𝑄(𝑟, ?̂?, 𝑡) ≈
1
4𝜋
𝑆0(𝑟, 𝑡) +
3
4𝜋
𝑆1⃗⃗ ⃗⃗ (𝑟, 𝑡) ∙ ?̂? (2A.4)  
Substituting Eq. (2A.3) and Eq. (2A.4) into Eq. (2A.1), the RTE can be 
respectively rewritten in scalar and vector forms as follows:  
 
1
𝑣
𝜕𝛷(𝑟, 𝑡)
𝜕𝑡
+ ∇ ∙  𝐽(𝑟, 𝑡) + μ𝑎𝛷(𝑟, 𝑡) = 𝑆0(𝑟, 𝑡) (2A.5)  
 
1
𝑣
𝜕𝐽(𝑟, 𝑡)
𝜕𝑡
+ (μ𝑎 + μ𝑠
′ ) 𝐽(𝑟, 𝑡) + 
1
3
∇𝛷(𝑟, 𝑡) = 𝑆1⃗⃗ ⃗⃗ (𝑟, 𝑡) (2A.6)  
This is called the P1 approximation. Here, 𝑆0(𝑟, 𝑡) ≡  ∫ 𝑄(𝑟, ?̂?, 𝑡)𝑑4𝜋 ?̂? is the total power 
per volume emitted outward from position 𝑟  at time t. μ𝑠
′ ≡  μ𝑠(1 − 𝑔)  is called the 
reduced scattering coefficient and 𝑔 is anisotropy factor, which is the mean cosine of the 
scattering angle, i.e., 𝑔 ≡ ∫ 𝑓(?̂?, ?̂?′)?̂? ∙ ?̂?′𝑑
4𝜋
?̂?′ . The P1 approximation is quite good 
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when μa << μs’, the phase function is not too anisotropic, and the source-detector 
separation is large compared to the mean free scattering length 1/ μs’. 
To derive the diffusion approximation, we make the assumptions: 
 𝑆1⃗⃗ ⃗⃗ (𝑟, 𝑡) = 0 (2A.7)  
 
1
|𝐽|
𝜕|𝐽|
𝜕𝑡
≪ 𝑣(μ𝑎 + μ𝑠
′ ) (2A.8)  
The first assumption is justified for isotropic sources. The second assumption 
effectively means that the left-hand-side term in Eq. (2A.8) is taken to be zero. The 
implication of the second assumption is best seen in the frequency domain. If the 
intensity of the source is sinusoidally modulated with angular frequency ω, the time 
dependence of the photon current 𝐽 is thus of the form e−iωt. The time derivatives can be 
replaced by multiplying by –iω and the second assumption (when μa << μs’) becomes 
ω/(v μs’) << 1. This means that the scattering frequency must be much larger than the 
modulation frequency, which is justified for biological tissues when the source 
frequencies are less than ∼ 1 GHz [125]. On the other hand, to obtain phase 
measurements with good signal-to-noise ratio, the 100 MHz frequency range is the one 
typically used for frequency-domain optical studies of biological tissues. With these two 
assumptions, Eq (2A.6) simplifies to Fick’s law of diffusion, i.e.,  
  𝐽(𝑟, 𝑡) = − 
1
3(μ𝑎 + μ𝑠′ )
∇𝛷(𝑟, 𝑡) (2A.9)  
Substituting Fick’s law into Eq (2A.5) leads to the time-dependent diffusion 
equation[126]: 
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  ∇ ∙ (D(𝑟)∇𝛷(𝑟, 𝑡)) − 𝑣μ𝑎(𝑟)𝛷(𝑟, 𝑡) −
𝜕𝛷(𝑟, 𝑡)
𝜕𝑡
= −𝑣𝑆0(𝑟, 𝑡) (2A.10)  
Here D(𝑟) ≡
v
3(μ𝑎(𝑟)+μ𝑠
′(𝑟))
 is defined as photon diffusion coefficient. For homogeneous 
media,  
  D∇2𝛷(𝑟, 𝑡) − vμa𝛷(𝑟, 𝑡) −
∂𝛷(𝑟, 𝑡)
∂t
= −v𝑆0(𝑟, 𝑡) (2A.11)  
2.AI.2 Semi-Infinite Solution  
We start with the diffusion equation for the fluence rate in a homogeneous 
medium (Eq (2A.11)) and assume the point source 𝑆0(𝑟, 𝑡) and the photon fluence rate 
Φ(𝑟, 𝑡) have the general forms: 
 𝑆0(𝑟, 𝑡) =  𝑆𝛿(𝑟)[1 + 𝐴]𝑒
−𝑖𝜔𝑡  (2A.12)  
 Φ(𝑟, 𝑡) = Φ𝑑𝑐(𝑟) + Φ𝑎𝑐(𝑟)𝑒
−𝑖(𝜔𝑡−𝜑(𝑟)) (2A.13)  
Here 𝛿(𝑟) is Dirac function and φ represents the phase difference between the source and 
detected lights. 
Substituting Eq (2A.12) and Eq (2A.13) into Eq (2A.11) leads to  
 (∇2 −
vμa
𝐷
)Φ𝑑𝑐(𝑟) = −
vS𝛿(𝑟)
𝐷
 (2A.14)  
 [∇2 −
vμa − 𝑖𝜔
𝐷
]Φ𝑎𝑐(𝑟) = −
vSA𝑒−𝑖𝜑(𝑟)𝛿(𝑟)
𝐷
 (2A.15)  
Eq (2A.14) is the steady-state diffusion equation, and Eq (2A.15) is the frequency-
dependent diffusion equation. 
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When we consider a homogeneous infinite medium, the following results can be 
derived from Eq (2A.14) and Eq (2A.15) [127]:  
 
Φ𝑑𝑐(r) =
vS
4𝜋𝐷
exp [−r (
vμa
𝐷 )
1 2⁄
]
r
 
(2A.16)  
 
Φ𝑎𝑐(r) =
vSA
4𝜋𝐷
exp {−r (
vμa
2𝐷)
1 2⁄
[(1 + 𝑥2)1 2⁄ + 1]
1 2⁄
}
r
 
(2A.17)  
 𝜑(r) = r (
vμa
2𝐷
)
1 2⁄
[(1 + 𝑥2)1 2⁄ − 1]
1 2⁄
 (2A.18)  
Here, r = |𝑟| and x is defined as 𝜔/𝑣μa.  
 
Figure 2.5 Semi-infinite-geometry model. z0 is the depth of the effective isotropic source 
inside the biological tissue and zb is the distance between the extrapolated boundary and 
the tissue surface. The extrapolated zero boundary condition can be satisfied by 
considering a negative isotropic imaging source located at z = -(z0 + 2zb). ρ is the source-
detector separation on the tissue surface. 
 
In most medical applications of in vivo diffuse optical spectroscopy, both the light 
source and the detector are on a tissue surface. Semi-infinite geometry is a particularly 
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useful assumption for optical measurements. One simpler boundary condition is a zero-
crossing point for the fluence rate at a distance, zb, outside of the tissue [125, 128]: 
 Φ (z = −zb) = 0 (2A.19)  
Here, 𝑧𝑏 =
2
3μs
1+𝑅𝑒𝑓𝑓
1−𝑅𝑒𝑓𝑓
  , where Reff is the effective reflection coefficient to account for the 
index mismatch between tissue and air: Reff = -1.44n
-2 
+ 0.71n
-1 
+ 0.668 + 0.064n and n is 
the ratio of refraction indices of tissue and air n= ntissue/nair ≃ 1.33. Eq. (2A.19) is called 
the extrapolated-zero boundary condition, which can be satisfied by considering a 
negative isotropic imaging source. Because a light beam incident upon the surface can be 
well represented by a single scatter source at a depth z0 equal to one effective photon 
mean free path (i.e., z0 ≈ 1/ µs’), the negative imaging source is located at –(z0 + 2zb). A 
solution for the diffusion equations Eq (2A.14) and Eq (2A.15) in the homogeneous 
semi-infinite medium model can be obtained by application of the superposition principle 
from Eq (2A.17) – Eq (2A.18): 
 
 
35 
 
Φ = Φ1𝑑𝑐 +Φ1𝑎𝑐𝑒
−𝑖(𝜔𝑡−𝜑1) −Φ2𝑑𝑐 −Φ2𝑎𝑐𝑒
−𝑖(𝜔𝑡−𝜑2)
= Φ1𝑑𝑐 −Φ2𝑑𝑐 + (Φ1𝑎𝑐𝑒
𝑖𝜑1 −Φ2𝑎𝑐𝑒
𝑖𝜑2)𝑒−𝑖𝜔𝑡  
=
vS
4𝜋𝐷
(
exp [−r1 (
vμa
𝐷 )
1 2⁄
]
r1
−
exp [−r2 (
vμa
𝐷 )
1 2⁄
]
r2
)
+
vSA
4𝜋𝐷
(
exp [−r1 (
vμa
2𝐷)
1 2⁄
] {[(1 + 𝑥2)1 2⁄ + 1]
1 2⁄
− 𝑖[(1 + 𝑥2)1 2⁄ − 1]
1 2⁄
}
r1
−
exp [−r2 (
vμa
2𝐷)
1 2⁄
] {[(1 + 𝑥2)1 2⁄ + 1]
1 2⁄
− 𝑖[(1 + 𝑥2)1 2⁄ − 1]
1 2⁄
}
r2
)𝑒−𝑖𝜔𝑡 
(2A.20)  
In Fig. 2.5, ρ is the projection of the source detector distance r1 on the interface 
plane (z = 0). r1 = √ρ2 + z02 , r2 = √ρ2 + (z0 + 2zb)2  . Assuming z0
2/ρ2 ≪ 1  and 
(z0 + 2zb)
2/ρ2 ≪ 1, we can carry over expansions to the second order in (z0 + zb ± zb) /ρ 
in Eq. (2A.20) and give the dc and ac photon fluence rate along -z direction and the 
phase lag φ between source and detector[104]:  
 
Φ𝑑𝑐(ρ) =
2𝑣2𝑆
(4𝜋)2𝐷
exp [−ρ(
vμa
𝐷 )
1 2⁄
]
ρ3
[1 + ρ (
vμa
𝐷
)
1 2⁄
] (𝑧𝑏 + 𝑧0) 
× {𝑧𝑏 +
3𝐷
𝑣
 [1 −
(𝑧𝑏 + 𝑧0)
2 + 3𝑧𝑏
2
2ρ2
(3 +
ρ2
vμa
𝐷
1 + ρ (
vμa
𝐷 )
1 2⁄
)]} 
(2A.21)  
 
Φ𝑎𝑐(ρ) =
2𝑣2𝑆𝐴
(4𝜋)2𝐷
exp [−ρ(
vμa
2𝐷)
1 2⁄
𝑉+]
ρ3
 (2A.22)  
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× [1 + ρ(
2vμa
𝐷
)
1 2⁄
𝑉+ + ρ2
vμa
𝐷
(1 + 𝑥2)
1
2]
1
2
(𝑧𝑏 + 𝑧0) 
×
{
 
 
𝑧𝑏 +
3𝐷
𝑣
 
[
 
 
 
1 −
(𝑧𝑏 + 𝑧0)
2 + 3𝑧𝑏
2
2ρ2
 
×
(
 2 +
1 + ρ (
vμa
2𝐷)
1
2
𝑉+
1 + ρ(
2vμa
𝐷 )
1 2⁄
𝑉+ + ρ2
vμa
𝐷
(1 + 𝑥2)
1
2
+ ρ(
vμa
2𝐷
)
1 2⁄
𝑉+
)
 
]
 
 
 
}
 
 
 
 φ(ρ) = ρ (
vμa
2𝐷
)
1 2⁄
𝑉− − 𝑎𝑟𝑐𝑡𝑎𝑛(
ρ (
vμa
2𝐷
)
1 2⁄
𝑉−
1 + ρ (
vμa
2𝐷)
1 2⁄
𝑉+
) (2A.23)  
Here, 𝑉+ = [(1 + 𝑥2)1/2 + 1]
1/2
, 𝑉− = [(1 + 𝑥2)1/2 − 1]
1/2
 and as defined previously 
x = 𝜔/𝑣μa.  
To consider a DOS measurement, Eq (2A.21) – Eq (2A.23) can be rewritten as 
following: 
 
ln {
ρ3Φ𝑑𝑐(ρ)
[1 + ρ (
vμa
𝐷 )
1 2⁄
] 𝐹𝑑𝑐(ρ, μa, 𝐷, 𝑧𝑏 , 𝑧0, 𝑣)
}
= −ρ (
vμa
𝐷
)
1 2⁄
+ 𝐺𝑑𝑐(𝐷, 𝑆, 𝑧𝑏 , 𝑧0 , 𝑣) 
(2A.24)  
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ln
{
 
 
 
 
ρ3Φ𝑎𝑐(ρ)
[1 + ρ (
2vμa
𝐷 )
1 2⁄
𝑉+ + ρ2
vμa
𝐷
(1 + 𝑥2)
1
2]
1
2
𝐹𝑎𝑐(ρ, μa, 𝐷, 𝑧𝑏 , 𝑧0, 𝜔, 𝑣)
}
 
 
 
 
= −ρ(
μa
2𝐷
)
1 2⁄
𝑉+ + 𝐺𝑎𝑐(𝐷, 𝑆, 𝐴, 𝑧𝑏 , 𝑧0, 𝑣) 
(2A.25)  
 φ(ρ) + 𝑎𝑟𝑐𝑡𝑎𝑛[𝐹φ(ρ, μa, 𝐷, 𝜔, 𝑣)] = ρ (
vμa
2𝐷
)
1 2⁄
𝑉− (2A.26)  
where ρ-dependent functions Fdc, Fad, and Fφ and ρ-independent functions Gdc, and Gac 
are defined by Eq (2A.24) – Eq (2A.26). In practice, multiseparation method are used the 
quantitive assessment of the absorption (µa) and the reduced scattering (µs’) coefficiens 
of tissues by the use of either the (Φac, φ) pair or (Φdc, φ) pair. Because Φac is less 
influenced by room light, we usually give µa and µs’ from (Φac, φ) pair. Moreover, the 
slope of ln (ρ
2
 Φac) approximates the slope of the complicated Eq (2A.25) under the the 
condition 𝜌√3μ𝑎μ𝑠 ′  ≫ 1, which can be satisfied in practical application [129]. 
Appendix II: Semi-infinite Solution of Correlation Diffusion Equation 
In DCS, the temporal autocorrelation function of the total scattered electric field 
is used to extract the dynamical information about the medium. Each dynamic light 
scattering event contributes to the detected correlation function. Ackerson and coworkers 
suggested that it is possible to understand the propagation of temporal autocorrelation in 
turbid media primarily by replacing radiance 𝐿(𝑟, ?̂?′, 𝑡) in the transport equation [Eq 
(2A.1)] with the unnormalized electric field temporal autocorrelation function 
𝐺1
𝑇(𝑟, ?̂?′, 𝜏) [130]. 
 
 
38 
 
∇ ∙ 𝐺1
𝑇(𝑟, ?̂?, 𝜏)?̂? + μ𝑡𝐺1
𝑇(𝑟, ?̂?, 𝜏) =
𝑄(𝑟, ?̂?)+ μ𝑠 ∫ 𝐺1
𝑇(𝑟, ?̂?′, 𝜏)𝑔1
𝑠(?̂?, ?̂?′, 𝜏)𝑓(?̂?, ?̂?′)𝑑
4𝜋
?̂?′. 
(2A.27)  
Eq (2A.27) is a steady-state equation applicable for CW sources. Here, 𝐺1
𝑇(𝑟, ?̂?′, 𝜏) =
 〈?⃗?∗(𝑟, ?̂?, 𝑡) · ?⃗?(𝑟, ?̂?, 𝑡 + 𝜏)〉 where ?⃗?(𝑟, ?̂?, 𝑡) is the electric field at position 𝑟 and time t 
propagating in the ?̂?  direction. 𝑔1
𝑠(?̂?, ?̂?′, 𝜏)  is the normalized temporal field 
autocorrelation function for single scattering and is given by 
 𝑔1 =
〈?⃗?∗(𝑡) · ?⃗?(𝑡 + 𝜏)〉
|?⃗?(𝑡)|
2 = 𝑒
𝑖𝜔𝜏𝑒−
1
6
𝑞2〈∆𝑟2(𝜏)〉
 (2A.28)  
Here 〈∆𝑟2(𝜏)〉 is the mean square displacement of a scatterer duing the delay time τ, and 
?⃗? is the scattered wavevector representing the difference between output and input beam 
wavevectors.  
After a set of steps identical to the steps used to derive the diffusion equation for 
photon fluence rate from the radiative transport equation, we get the correlation diffusion 
equation [56, 57], 
 [∇ · (𝐷(𝑟)∇) − vμa(𝑟) −
𝛼
3
𝑣μ𝑠
′𝑘0
2〈∆𝑟2(𝜏)〉] 𝐺1(𝑟, 𝜏) = −v𝑆0(𝑟) (2A.29)  
Here, 𝐺1(𝑟, 𝜏) = ∫𝐺1
𝑇(𝑟, ?̂?, 𝜏)𝑑?̂? = 〈?⃗?∗(𝑟, 𝑡) · ?⃗?(𝑟, 𝑡 + 𝜏)〉  is the un-normalized 
temporal field autocorrelation function and k0 = 2π/λ is the wavenumber of the CW light 
in the medium. Biological tissues contain static scatterers (e.g. organelles, etc.) and 
moving scatterers (e.g., red blood cells). The scattering events from the static scatterers 
do not contribute to the phase shift. Here we use α (a unitless factor) to represent the 
percentage of light scattering events from moving scatterers. For a simple case of a point 
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source in a semi-infinite homogeneous medium, the correlation diffusion equation with 
the extrapolated zero boundary condition becomes 
 [∇2 − (
vμa
𝐷
+
𝛼
3
𝑣
𝐷
μ𝑠
′𝑘0
2〈∆𝑟2(𝜏)〉)] 𝐺1(𝑟, 𝜏) = −
v𝑆0𝛿(𝑟)
𝐷
, (2A.30)  
 𝐺1(z =-𝑧𝑏 , τ) = 0. (2A.31)  
The analytical solution of the correlation diffusion equation will have the same form as 
Eq (2A.20), 
 𝐺1(𝜌, 𝜏) =
vS0
4𝜋𝐷
(
e−𝐾(𝜏)𝑟1
𝑟1
−
e−𝐾(𝜏)𝑟2
𝑟2
) (2A.32)  
Here, 𝜌 is the source-detector separation, r1 = √ρ2 + z02, and r2 = √ρ2 + (z0 + 2zb)2. 
𝐾(𝜏) = √
𝑣
𝐷
(μa +
𝛼
3
μ𝑠′𝑘0
2〈∆𝑟2(𝜏)〉) . 
Appendix III: Differential Pathlength Factors 
In the semi-infinite geometry, an approximation can be made for the dc photon 
fluence rate in Eq. (2A.21) [104, 129], 
 Φ𝑑𝑐(ρ) = C
exp(−ρ√3μ𝑠
′μ𝑎 )
ρ2
(
1
ρ
+ √3μ𝑠′μ𝑎 ) (2A.33)  
where C is a proportionality factor and μs’ is assumed to be constant. Assuming μa = 
μa0+Δμa and Δμa/ μa0 << 1, we can get 
 −ln
Φ𝑑𝑐
Φ𝑑𝑐0
≈ ∆μ𝑎 ∙ ρ ∙
√3μ𝑠′
2√μ𝑎0 
ρ√3μ𝑠′μ𝑎0 
1 + ρ√3μ𝑠′μ𝑎0 
 (2A.34)  
which, after comparison with Eq (2.6), gives 
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DPF𝑠𝑒𝑚𝑖𝑖𝑛𝑓 =
√3μ𝑠′
2√μ𝑎0 
ρ√3μ𝑠′μ𝑎0 
1 + ρ√3μ𝑠′μ𝑎0 
=
√3μ𝑠′
2√μ𝑎0 
(1 −
1
1 + ρ√3μ𝑠′μ𝑎0 
) 
(2A.35)  
In an infinite turbid medium, DPF can be derived from Eq (2A.16) as follows: 
 DPF𝑖𝑛𝑓 =
√3μ𝑠′
2√μ𝑎0 
 (2A.36)  
Comparing with Eq (2A.35), we can see that DPFsemiinf increases with source–detector 
distance ρ and reaches DPFinf when ρ√3μ𝑠′μ𝑎0 ≫ 1. 
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CHAPTER 3 SIMULTANEOUSLY EXTRACTING MULTIPLE PARAMETERS 
VIA FITTING ONE SINGLE AUTOCORRELATION FUNCTION CURVE IN 
DCS 
3.1 Introduction 
To assess individual tumor hemodynamic changes over time or the diversity 
between different patients, further improve the accuracy of blood flow index extraction 
method is necessary in DCS data analysis. In addition, the measured light intensity 
autocorrelation function is determined by not only blood flow, but also tissue optical 
properties (i.e., μa and μs’) and a coherence factor β. β relies mainly on light source and 
detection optics. It is thus desirable to extract as much information as possible (i.e., 
multiple parameters) from one single autocorrelation function. Some previous studies 
have chosen to use the values of μa and μs’ from literature respective to the measured 
tissue type (e.g., brain or muscle) for the calculation of DCS blood flow [66, 86]. These 
assumptions are susceptible to deviations in tissue optical properties [111]. A few of 
recent studies have employed hybrid instruments (DOS and DCS) allowing for 
concurrent measurements of both μa and μs’ to extract accurate BFI [67, 83, 88, 131]. In 
addition, most previous studies estimated β based on the Siegert relation using the 
measured autocorrelation function data at the earliest correlation delay time, and then 
fitted BFI (i.e., two-step fitting method) [65, 71, 84, 85, 97]. Although a few recent 
studies claimed fitting β and BFI simultaneously [131-133], none of them have compared 
the performance of the two methods (i.e., simultaneous fitting versus two-step fitting). 
The present study is designed to investigate the possibility of simultaneously 
extracting multiple parameters such as μa, μs’, β, and BFI through fitting one single 
 
 
42 
autocorrelation function curve and evaluate the performance of different fitting methods. 
For this purpose, computer simulations, tissue-like phantom experiments, and in-vivo 
tissue measurements were utilized. It is expected that the outcomes from this study will 
ultimately improve DCS data analysis.  
The work reported in this chapter has been previously published [134] and reprint 
permission for this dissertation has been granted by the publisher. 
3.2 Methods and Materials 
3.2.1 DCS for Flow Measurements  
The BFI is quantified by a DCS flowmeter built in our laboratory. Details about 
DCS for flow measurements can be found in Section 2.2.  
3.2.2 Noise Model for Simulation of Autocorrelation Functions 
In order to simulate autocorrelation functions measured in real media, a proper 
estimate of measurement noises is needed. Previously, a noise model with single 
scattering limit in fluorescence correlation spectroscopy [135] has been adopted for use in 
diffuse correlation experiments wherein photons experience multiple scattering events 
[75, 81]. The phantom experiments demonstrated that the noise model provided a good 
estimate of DCS measurement noises in homogeneous media with infinite geometry. 
Briefly, the measured correlation function [g2(τ) – 1] was assumed to decay 
approximately exponentially, i.e.,      exp12g . The experimental configuration 
was characterized by the correlator bin time interval T, bin index m corresponding to the 
delay time τ, average number of photons <n> within T [i.e., <n> = I·T, where I was the 
detected photon intensity], total averaging time t, and coherence factor β. The noise 
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[standard deviation σ(τ)] of the measured correlation function [g2(τ) – 1] at each delay 
time τ was estimated to be [81, 135]: 
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(3.1)  
Accordingly, the signal-noise-ratio (SNR) of DCS measurements at delay time τ was 
 
 
 


12 
g
SNR , and 1/SNR(τ) can be used to estimate the noise level of DCS 
measurements. 
For the case of diffuse reflectance measurement on medium surface, a semi-
infinite geometry should be considered instead and Eq (2.10) should be used to calculate 
[g2(τ) - 1] rather than the assumption of exponential decay function as used in Reference 
[81]. However, mathematically it is difficult to derive a noise model based on the 
complex Eq (2.10). In the present study, we designed phantom experiments to test the 
accuracy of this noise model (Eq (3.1) for use in homogeneous media with semi-infinite 
geometry. Tissue-like liquid phantoms were created with Intralipid for control of 
scattering (μs’) and particle Brownian motion (αDB), India ink for control of absorption 
(μa), and distilled water [111]. Although temperature can affect Brownian motions (αDB) 
of Intralipid particles, the room temperature was controlled constant (~23 °C) in order to 
obtain stable αDB (flow). Tissue-like liquid phantoms have been commonly used for the 
calibration of DCS techniques [56, 58, 111]. The phantom was contained in a glass 
aquarium. A fiber-optic probe with a pair of source and detector fibers at a distance of 2.5 
cm was secured in contact with the surface of the liquid phantom solution using a 
custom-designed holder. We set constant μs′ = 8 cm
−1
 and vary μa (0.075, 0.100, 0.150 
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cm
-1
) by adding ink to test the noise-model under different levels of noise. Higher μa was 
associated with lower number of photons detected (I), thus leading to higher level of 
noise [σ(τ)]. 
After the noise model was verified for semi-infinite geometry, it was used to 
generate the normalized intensity autocorrelation curve g2 with noise. An autocorrelation 
curve (g2) was firstly generated using Eq (2.10) and Eq (2.12). The standard deviation 
σ(τ) of [g2(τ) – 1] was then calculated using Eq (3.1), wherein the β and Γ were obtained 
concurrently by fitting the g2 curve with the exponential approximation (the concurrent 
fitting method can be found in Section 3.2.4), i.e.,      exp12g . Following a 
Gaussian distribution with zero mean and standard deviation σ(τ), noises that varied at 
different delay time τ were generated. The simulated noises were then applied on g2(τ) to 
create an intensity autocorrelation curve with noise. As indicated in Eq (3.1), the SNR 
and noise level (1/SNR) of simulated autocorrelation functions were adjusted by 
changing the light intensity or photon count rate (I = <n>/T). 
3.2.3 Extraction of Multiple Parameters through Fitting One Single Autocorrelation 
Curve 
Multiple parameters examined (i.e., αDB, μa, μs’, and β) were extracted by fitting 
the measured autocorrelation function curve to the analytical solution of correlation 
diffusion equation (Eq (2.10)). The goal was to minimize the sum of squared differences 
(SSD) between the measured and calculated autocorrelation functions. The minimization 
of the objective function SSD = ∑[g2,m(τ) - g2,c(τ)]
2
 was done by using Nelder-Mead 
simplex algorithm (fminsearch function) in Matlab (Mathwork, Inc., MA), where g2,m(τ) 
was the measured intensity autocorrelation function and g2,c(τ) was the analytical model 
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of autocorrelation in the semi-infinite reflection geometry (Eq (2.10)). Initial guesses for 
these parameters were assigned randomly using the “rand” function in Matlab. The 
random variation ranges of these parameters were determined based on the dynamic 
ranges in DCS phantom experiments and in-vivo measurements: μa = 0.05 to 0.4 cm
-1
, μs’ 
= 2 to 15 cm
-1
, αDB = 0.4 to 2 × 10
-8
 cm
2
/s, and β = 0.1 to 0.9. We set the termination 
tolerance for the fitted variables at 10
-11
, which is ~1000 times smaller than the value of 
αDB (0.4 to 2 × 10
-8
 cm
2
/s). This termination criterion is strict enough to obtain precise 
results for all four parameters.  
In order to determine the possibility of fitting μa, μs’ or β along with αDB from 
one single autocorrelation curve, we examined the SSD change patterns by varying three 
pairs of the four parameters (i.e., μa and αDB, μs’ and αDB, β and αDB), respectively. For 
this purpose, a reference light intensity autocorrelation curve without noise, g20, was 
initially generated using Eq (2.10) and Eq (2.12) with the given parameters: μa = 0.12 
cm
-1
, μs’ = 8 cm
-1
, αDB = 10
-8
 cm
2
/s, and β = 0.45. The paired parameters were then 
varied to generate multiple testing autocorrelation curves. The variation ranges of these 
parameters were the same as those indicated above. The SSDs between the testing 
autocorrelation curves and the reference autocorrelation curve g20 were calculated and 
presented in contour plots as functions of these paired parameters, respectively. Different 
SSD patterns (e.g., convergence or divergence) implied the possibility of extracting 
multiple parameters from one single autocorrelation curve.  
The possibility of extracting multiple parameters was further examined by fitting 
the paired parameters simultaneously from the reference autocorrelation curve g20 with 
two different levels of noise (I = 100 and 50 kcps). For each noise level, 1000 simulated 
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curves were generated and fitted to extract the paired parameters simultaneously. The 
discrepancies between the fitted and given values of the paired parameters are expressed 
as "percentage errors". 
3.2.4 Comparison of Two Methods for Extracting β and αDB 
In most previous studies, extracting αDB began with using Eq. (2.12) to determine 
β. Using DCS measured g2 data at earliest τ and letting g1 ≈ 1 [i.e., 
      10,/0,0, 111   GGg ] led to 1)0,(2   g . Using ),(2 g  , β and Eq 
(2.12), ),(1 g  was calculated for all τ. Equation (2.10) was then used with the 
unknown parameter αDB to fit the ),(1 g  derived from DCS measurements. In addition, 
one could also average more g2 datasets (i.e., several data points instead of one single 
data point) at early τ to reduce the noise influence for determining β. 
During the study of extracting multiple parameters from one single 
autocorrelation curve (see Section 3.2.3), we found it possible to simultaneously fit both 
β and αDB (see Sections 3.3.1 and 3.3.3). To compare the performance between the two 
methods (i.e., two-step fitting versus simultaneously fitting) for extracting β and αDB, 
computer simulations, phantom experiments and in-vivo tissue measurements were 
utilized. For simulations, the reference autocorrelation curves g20 with noise were 
generated based on the procedures described in Section 3.2.2, and the levels of noise 
were changed by varying photon count rate from 20 to 500 kcps. At each noise level, 
1000 curves were created and fitted by the two methods to examine if they were able to 
extract the expected values of β and αDB from the simulated curves. 
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The simulation results were further verified with the data collected from the 
phantom experiments (see Section 3.2.2) and in-vivo tissue measurements in forearm 
flexor muscle. A single-mode detector fiber was placed at a distance of 2.5 cm from the 
source fiber for the phantom or tissue measurement. The source and detector fibers were 
confined in their positions by a foam pad to form a fiber-optic probe which was placed on 
the surface of the measured phantom or tissue. The in-vivo measurement was taken from 
one healthy volunteer who signed the informed consent approved by the University of 
Kentucky Institutional Review Board. Before the experiment, absolute values of tissue 
optical properties (μa and μs’) in forearm flexor muscle were measured by a frequency-
domain NIR tissue-oximeter (Imagent, ISS Inc., IL). The measured μa and μs’ were used 
as input parameters in calculation of β and αDB with the two methods. To reduce the 
influence of physiological variations, the baseline drift of the in-vivo tissue measurement 
was removed using a first order high-pass Butterworth filter with a cutoff frequency of 
0.05 Hz. For statistical analyses, significances of the difference between the two methods 
were tested using a paired t-test. The criterion for significance is p < 0.05. 
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3.3 Results 
3.3.1 The Noise Model Used in Homogeneous Media with Semi-infinite Geometry 
 
Figure 3.1 Tissue-like phantom experiments to verify the feasibility of applying the noise 
model in homogeneous media with semi-infinite geometry. DCS measurements were 
performed in three liquid phantoms with different μa (0.075, 0.100, 0.150 cm
-1
) to test the 
noise model under different noise levels. Higher μa was associated with lower number of 
photons detected (I), thus leading to higher measurement noise [σ(τ)] and lower signal-to-
noise ratio [SNR(τ)]. (a) Comparison of the measurement noises between the measured 
autocorrelation curves from the phantoms (dots) and calculated noises predicted by the 
noise model (solid curves). The measurement noise decreased as the delay time τ 
increased. The “steps” were due to the multi-tau arrangement of the correlator. (b) 
Comparison of the SNRs between the measured autocorrelation curves and model 
predictions. Although the measurement noise decreased as the delay time τ increased, the 
SNR of DCS measurement also decreased because the “signal” dropped even faster than 
the noise as τ increased. 
 
Figure 3.1 shows the results from phantom experiments to verify the feasibility of 
applying the noise model in homogeneous media with semi-infinite geometry. During the 
three titrations of varying μa (0.075, 0.100, 0.150 cm
-1
) while keeping μs′ constant (8 
cm
−1
), photon counting rates changed correspondingly (66, 41, 20 kcps). 267, 237 and 
235 autocorrelation curves were collected sequentially at the three titration steps. The 
noise [σ(τ)] (Fig. 3.1a) and SNR (Fig. 3.1b) of the autocorrelation function at each τ 
were calculated and plotted (see the dots in Fig. 3.1). The solid curves represent the 
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calculated noises or SNRs using Eq (3.1) with the parameters obtained from the phantom 
experiments; β and Γ were obtained simultaneously by fitting the experimental data with 
the exponentially decaying function (see Sections 3.2.3 and 3.2.4); the averaging time to 
obtain one correlation function curve was kept constant (t = 1 s) for all measurements; the 
photon count rates were recorded by the correlator board; the bin time interval T was 121 
ns for the first 32 channels and doubled every 16 channels thereafter. As shown in Fig. 
3.1, the measurement noise decreased as the delay time τ or light intensity increased, 
whereas the SNR increased as the light intensity increased and changed with the variation 
of delay time τ. These results are consistent with the predictions from Eq (3.1) and 
suggest that the noise model provides a good estimate for DCS noises measured in 
homogeneous media with semi-infinite geometry.  
 
Figure 3.2. Comparison of the simulated and measured g2 curves at three different levels 
of noise: (a) I = 66 kcps; (b) I = 41 kcps; and (c) I = 20 kcps. The input parameters for 
simulation were acquired from the phantom experiments. 
 
We then used this noise model to generate autocorrelation curves (g2) with three 
different levels of noise (I = 20, 41, 66 kcps) observed in phantom tests. Figure 3.2 (a, b, 
c) shows the results comparing the simulated and measured (from phantoms) g2 curves 
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with the same levels of noise. Again, the results demonstrate that the noise model works 
well in homogeneous media with semi-infinite geometry. 
3.3.2 Extracting Multiple Parameters from One Single Autocorrelation Curve 
As indicated in Section 3.2.3, a reference g2 curve without noise was generated 
with the given parameters: μa = 0.12 cm
-1
, μs’ = 8 cm
-1
, αDB = 10
-8
 cm
2
/s, β = 0.45. The 
SSDs between the reference curve g20 and the testing curves generated by varying the 
values of paired parameters were calculated and presented in Fig. 3.3. The SSD values 
were marked on the curves.  
 
Figure 3.3. Contour plots of sum of squared differences (SSD) between a reference 
autocorrelation curve g20 obtained with the given parameters [αDB = 10
-8
 cm
2
/s, μa (785 
nm) = 0.12 cm
-1
, and μs’ (785 nm) = 8 cm
-1
] and the testing curves generated by varying 
the values of paired parameters. The true reference values of g20 are marked at the cross. 
(a) The SSDs obtained by varying μs’ from 2 to 15 cm
-1
 and αDB from 0.4 to 2 × 10
-8 
cm
2
/s. The dashed black curve represents the points at which local minima were achieved 
with compositions of μs’ and αDB. (b) The SSDs obtained by varying μa from 0.05 to 0.4 
cm
-1
 and αDB from 0.4 to 2 × 10
-8 
cm
2
/s. The dashed black curve illustrates the points at 
which local minima were achieved. (c) The SSDs obtained by varying β from 0.1 to 0.9 
and αDB from 0.4 to 2 × 10
-8 
cm
2
/s. The minimum value of SSD was reached at the true 
reference values of β and αDB. 
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Different patterns of SSD were observed for different pairs of parameters. The 
curves for the pairs of μs’/αDB (Fig. 3.3a) and μa/αDB (Fig. 3.3b) were divergent 
although the proportional relationships between the two paired parameters were opposite. 
Large crosstalk existed between αDB and μa or αDB and μs’, even if when the SSDs were 
close to zero (see the dashed curves in Fig. 3.3a and Fig. 3.3b). Due to the fact that the 
SSD was a highly nonlinear function of μa, μs’, β and αDB, the points on the dashed lines 
did not have exactly the same SSD value with one another, but the differences among 
these values were extremely small. Although the cross (+) point (with the true reference 
values) was the absolute minimum, there were numerous local minima along the dashed 
line. This made it difficult to obtain the absolute minimum at the cross point because the 
searching algorithm could get stuck easily in a local minimum. Conversely, the curves for 
the pairs of β and αDB (Fig. 3.3c) were convergent. The minimum value of SSD was 
reached at the true reference values of β and αDB (the cross point). In total, these results 
suggest that it is possible to fit β and αDB simultaneously and precisely.  
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3.3.3 Simultaneously Fitting μa, μs’ or β along with αDB from One Single Autocorrelation 
Curve  
 
Figure 3.4 Percentage errors when simultaneously fitting three pairs of four variables 
respectively from the simulated autocorrelation curves (g20) generated at two different 
levels of noise. The initial guesses of the fitted variables were assigned randomly when 
fitting each of the 1000 simulated g20 curves. The discrepancies between the fitted and 
given values of the paired parameters are expressed as "% errors”. The upper (a and b) 
and lower (c and d) panels represent simulation results with two different levels of noise 
(I = 100 and 50 kcps). Higher noise level caused larger evaluation errors. The left panel 
(a and c) shows the results when simultaneously fitting αDB and μs’ or αDB and μa. Large 
crosstalk between the paired parameters was apparent, resulting in large estimation 
errors. The right panel (b and d) shows the results when simultaneously fitting β and αDB. 
The estimation errors for both β and αDB were much smaller than those shown in the left 
panel (a and c). 
 
The results we got from Section 3.3.2 were further confirmed by simultaneously 
fitting the simulated autocorrelation g20 curves with different levels of noise. Figure 3.4 
shows the fitting results for extracting the three pairs of parameters simultaneously. The 
upper (Fig. 3.4a and Fig. 3.4b) and lower (Fig. 3.4c and Fig. 3.4d) panels represent the 
simulation results with two different levels of noise (I = 100 and 50 kcps). As expected, 
simultaneously fitting μa and αDB may result in estimation errors; 
underestimating/overestimating μa of -60%/+200% led to flow index errors up to -
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100%/+50%. Simultaneously fitting μs’ and αDB may generate even larger errors than 
simultaneously fitting μa and αDB; underestimating/overestimating μs’ from -40%/+200% 
led to flow index errors up to +120%/-80%. These errors were mainly due to the crosstalk 
between the paired parameters. By contrast, when fitting β and αDB simultaneously, the 
output values of fitted parameters (β and αDB) clustered around the true values (Fig. 3.4b 
and Fig. 3.4d). The estimation errors for both β and αDB at the two noise levels were 
smaller than 15%. 
3.3.4 Comparison of Two Methods for Extracting β and αDB  
The results shown in Sections 3.3.2 and 3.3.3 indicate that β and αDB can be 
simultaneously extracted by fitting one single autocorrelation curve. To compare the 
performance of the concurrent-fitting method with the conventional two-step fitting 
method (i.e., first calculating β and then fitting αDB) for extracting β and αDB, computer 
simulations, phantom experiments, and in-vivo tissue measurements were conducted in 
the present study.  
 
Figure 3.5 Comparison of the two methods for extracting β and αDB from the simulated 
g20 curves under different noise levels (i.e., the photon count rate changes from 500 kcps 
to 20 kcps). Dashed lines indicate the expected values (β = 0.45 and αDB = 1 × 10
-8 
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cm
2
/s). For both methods, the standard deviation (error bar) of the fitted values increased 
with the increase of noise level. Fitting β and αDB simultaneously resulted in unbiased 
and more accurate estimation of the means and smaller standard deviations compared to 
the two-step fitting method. When estimating β from the first point (a and b), the 
standard deviations of β and αDB were large. Estimating β from more points (c and d) 
reduced the standard deviations of estimation with the cost of estimation biases in β and 
αDB. 
 
Figure 3.5 shows the comparison results from the simulated g20 curves with 
different levels of noise (i.e., photon count rate varied from 20 to 500 kcps). For the two-
step method, we used either the first data point (upper panel) or averaged seven data 
points (lower panel) of g20 at early delay time τ to estimate β. For both concurrent and 
two-step fitting methods, the standard deviation of fitted values increased with the 
increase of noise level. However, simultaneously fitting β and αDB generated more 
accurate values with significantly smaller standard deviations (error bars) compared to 
the two-step fitting method (p < 0.001). Inaccurate estimation of β resulted in errors in 
fitting αDB, which became more remarkable when the noise level increased. As expected, 
using one point to estimate β resulted in large standard deviations of estimation, which 
can be reduced by averaging more data points (7 points in this simulation) of g20. Because 
of the decay of autocorrelation curve with τ (see Fig. 3.2), however, the averaging led to 
significant underestimations of β and αDB (p < 0.001).  
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3.3.5 Phantom Experiments and In Vivo Tissue Measurements 
 
Figure 3.6. The performance of the two fitting methods evaluated with the (a) phantom 
test and (b) in-vivo measurement. The mean values obtained by the simultaneous fitting 
method were assumed as ‘true’ values, and the discrepancies between the values 
extracted using the simultaneously fitting method or two-step fitting method are 
presented as percentage errors. The error bars are shown with crosses respectively and the 
mean values are located at the center of the crosses. 
 
Figure 3.6a shows the estimation deviations of β and αDB from the phantom 
experiments described in Section 3.2.2. Notice that only the data from the second step of 
titration (μa = 0.10 cm
-1
) are presented although the results from the other two steps (μa = 
0.075 and 0.15 cm
-1
) were similar. Since the concurrent-fitting method generated accurate 
estimates for β and αDB (see simulation results above), the mean values of β and αDB 
obtained by this method were assumed to be ‘true’ values of the measured phantom. The 
percentage deviations of β and αDB estimated from each autocorrelation curve are 
presented as error bars in Fig. 3.6a. Compared to the concurrent-fitting method, 
inaccurate estimation of β by the two-step fitting method may result in significant 
estimation errors in αDB (p < 0.001) and lead to larger error bars.  
Similarly, Fig. 3.6b shows the estimations of β and αDB from the data collected in 
in-vivo tissue measurements described in Section 3.2.4. 574 autocorrelation curves were 
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collected from the subject’s forearm using the DCS device. The results shown in Fig. 
3.6b agreed with those of the simulations shown in Fig. 3.5 and the phantom experiments 
shown in Fig. 3.6a. 
3.4 Discussion and Conclusions 
This study was designed to investigate the possibility of extracting multiple 
parameters such as μa, μs’, β, and αDB through fitting one single autocorrelation function 
curve and compare the performance of different fitting methods. For this purpose, the 
patterns of the sum of squared differences (SSD) between the reference autocorrelation 
curve (g20) and the testing autocorrelation curves generated by varying the values of 
paired parameters were examined; different SSD patterns (e.g., convergence or 
divergence) implied the possibility of extracting multiple parameters from a single 
autocorrelation curve. These results were then verified by computer simulations, phantom 
experiments and in-vivo tissue measurements.  
For simulations with our measurement configuration, a noise model for 
homogeneous media with semi-infinite geometry is needed to generate autocorrelation 
curves with noise. Previous studies have used a noise model described in Section 3.2.2 as 
an approximation [75, 81], which has never been validated in semi-infinite geometry. In 
the present study, we designed phantom experiments to test the accuracy of this noise 
model for use in homogeneous media with semi-infinite geometry. The phantom 
experimental results agreed with the theoretical predictions from the noise model (Fig. 
3.1a and Fig. 3.1b) suggesting that it provides a good estimate for DCS noises measured 
in homogeneous media with semi-infinite geometry. This noise model was thus used to 
generate autocorrelation curves with different levels of noise, and the simulated curves 
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were compared with the curves collected from phantom measurements (Fig. 3.2a, Fig. 
3.2b and Fig. 3.2c). The comparison results confirmed that this noise model worked well 
in homogeneous media with semi-infinite geometry. 
To investigate the possibility of fitting μa, μs’ or β along with αDB from one single 
autocorrelation curve, we examined the SSD change patterns by varying three pairs of the 
four parameters. According to the results, a large crosstalk between the αDB and μa or 
αDB and μs’ (Fig. 3.3a and Fig. 3.3b) existed, suggesting that it is impractical to 
simultaneously extract αDB and μa or αDB and μs’ from one single autocorrelation curve. 
Conversely, the SSD curves for the pairs of β and αDB were convergent, suggesting a 
possibility to extract β and αDB simultaneously. These results were then verified by 
simultaneously fitting the paired parameters from the simulated autocorrelation curves 
with noise generated by the noise model. Fitting αDB and μa or αDB and μs’ 
simultaneously caused large estimation errors (Fig. 3.4a and Fig. 3.4c) that were majorly 
due to the large crosstalk between the paired parameters. These simulation results (Fig. 
3.4a and Fig. 3.4c) agree very well with our previous findings in phantom titration tests 
(see Fig. 6 in Ref. [111]). By contrast, when fitting β and αDB simultaneously, the 
estimation errors for both parameters were much smaller (Fig. 3.4b and Fig. 3.4d), 
although they were increased with the increase of noise level. 
Upon examination of the K(τ) definition [see Eq. (2.10)], the crosstalk between 
αDB and μa or αDB and μs’ is expected as these paired parameters can compensate each 
other to generate a similar autocorrelation curve. The decay of an autocorrelation curve is 
determined by K(τ) which can be rewritten as:    
2
1
2
0
'
'2
1
2
0
2'' 21363
















 



a
Bs
saBssa
Dk
DkK . It 
is apparent from this expression that the decay of an autocorrelation curve is influenced 
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by the term of 
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
a
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2
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2  and a variation in αDB can be compensated by a variation in μa or 
μs’. By contrast, based on Eq (2.10) and Eq (2.12), β does not affect the decay of the 
autocorrelation curve and does not compensate the variation of αDB. Therefore, it is 
possible to fit β and αDB simultaneously without causing the crosstalk between them. 
We then compared the two methods for extracting β and αDB. All the results from 
the simulations (Fig. 3.5), phantom experiments (Fig. 3.6a), and tissue measurements 
(Fig. 3.6b) suggested that simultaneously fitting β and αDB from the entire 
autocorrelation curve resulted in more accurate values with smaller standard deviations 
compared to the two-step fitting method. For the two-step fitting method, large standard 
deviations of estimation resulted mainly from the inaccurate β estimated using only 
several points at early τ of g2 curve; limited datasets may be contaminated by noises. The 
estimation bias was due to the decay of autocorrelation curve with τ, which led to 
underestimations of β and αDB. 
In conclusion, the possibility of extracting multiple parameters (αDB, μa, μs’ and β) 
via fitting one single autocorrelation function curve has not previously been investigated 
for DCS measurements. It is not trivial to get the answer regarding such possibility 
because the autocorrelation function depends on all four parameters (see Eq (2.10) and 
Eq (2.12)) and explicitly expressing the relations among them is difficult. In the present 
study, for the first time, we comprehensively investigated the possibility of fitting 
multiple parameters from one single autocorrelation curve and evaluated the performance 
of the two methods with computer simulations, tissue-like phantom experiments and in-
vivo tissue measurements. The results from this study suggest that it is impractical to 
simultaneously fit αDB and μa or αDB and μs’ from one single autocorrelation function 
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curve due to the large crosstalk between these paired parameters. However, simultaneous 
fitting of β and αDB is feasible and generates more accurate estimation with smaller 
standard deviation compared to the conventional two-step fitting method. 
The outcomes from this study imply that absolute values of μa and μs’ are needed 
for extracting accurate β and αDB. Our laboratory has recently developed a hybrid NIR 
diffuse optical instrument combining a commercial frequency-domain tissue-oximeter 
and a DCS flowmeter, which allows for simultaneous measurements of μa and μs’ as well 
as β and αDB [85]. This hybrid NIR diffuse optical instrument meets the need of absolute 
values of μa and μs’ for extracting accurate β and αDB. It is expected that the use of this 
type of hybrid instrument and simultaneous fitting algorithms will provide accurate 
measurement results. 
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CHAPTER 4 DIFFUSE OPTICAL MONITORING OF HEAD AND NECK 
TUMOR BLOOD FLOW AND OXYGENATION DURING RADIATION 
DELIVERY 
4.1 Introduction 
As described in Chapter 1, oxygen must be present during or within milliseconds 
after the radiation exposure delivery of the radiation dose [12]. Potential instant changes 
in tumor hemodynamics during radiation delivery may affect the treatment efficacy. For 
example, Yu et al [65] have used a NIR diffuse correlation spectroscopy (DCS) for 
noninvasively monitoring tumor blood flow changes during photodynamic therapy 
(PDT). They observed a rapid flow decrease in murine tumors during PDT light 
illumination, leading to a poor long-term treatment efficacy [65]. With these results, we 
want to test the hypothesis that that continuous monitoring of tumor hemodynamics 
during radiation delivery may also assist in assessing treatment outcomes. 
For this purpose, a customer-designed fiber-optic probe connected to the DCS 
flow-oximeter was placed directly on the surface of the radiologically/clinically involved 
cervical lymph node. The DCS flow-oximeter, located in the radiation treatment room, 
was remotely operated by a computer in the control room. From the early measurements, 
abnormal optical signals were observed when the optical device was placed in close 
proximity of the primary x-ray beams. Phantom tests were then designed to identify the 
source of artifacts. Thereafter, the radiation-generated artifacts were avoided by moving 
the optical device away from the primary x-ray beams. With the new experimental setup, 
tumor hemodynamic responses to radiation treatment were successfully measured. To the 
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best of our knowledge, these are the first noninvasive measurements of tumor 
hemodynamic changes during x-ray radiation delivery. 
Part of the work reported in this chapter has been previously published [116] and 
reprint permission for this dissertation has been granted by the publisher. 
4.2. Methods and Materials 
4.2.1 Patient Characteristics and Treatment Protocol 
Fifty-three patients undergoing chemo-radiation therapy for head and neck tumors 
participated in this study with the signed consents approved by the University of 
Kentucky Institutional Review Board (IRB). Based on the source-detector (S-D) 
separation of 2.5 cm set in our fiber-optic probe (see Section 4.2.2), we included only 
Stage III-IVb SCCHN with a cervical tumor node larger than 2 cm detected by 
CT/PET/MRI scan or ultrasound machine. Patients with supraclavicular adenopathy were 
not enrolled as there was a possibility of the primary origin from other sites in the chest 
such as lung or esophagus. 
Radiotherapy in combination with traditional chemotherapy was applied on these 
patients. Each patient received daily fractional radiation over ~7 weeks. A total dose of 70 
Gy was delivered in once daily fractions of 2 Gy. For chemotherapy, the cisplatin was 
given at 100 mg/m
2
 on Day 1 and Day 22 of radiation. The role of chemotherapy 
(cisplatin) in head/neck cancer is to increase the incidence of double strand breaks 
(radiosensitization) and decrease the incidence of metastatic disease.  
During radiation delivery, the patient was immobilized on the treatment table with 
pre-molded plastic mask (see Fig. 4.1a and Fig. 4.1b). Radiation was delivered in the 
 
 
62 
form of high-energy x-ray beams (6 MV) produced by a medical linear accelerator 
(Clinac 21EX, Varian Medical Systems, USA).  The X-ray source was mounted on the 
end of an L-shaped gantry that can be rotated in a plane 360º around the longitudinal axis 
of the patient (see Fig. 4.1a). In this configuration, the x-ray source circumscribed a 
circle having a radius of 100 cm and always pointed toward the longitudinal patient axis. 
This allowed the x-ray beam to be focused to a point in the patient. Seven to nine source 
positions were approximately equally spaced over 360º around the patient. A typical 
treatment required approximately 15 minutes to complete, of which 3 to 4 minutes was 
actual radiation delivery. The radiation treatment consisted of a series of several short x-
ray exposures (“beam-on”) followed by periods of no radiation (“beam-off”). 
 
Figure 4.1. A remotely operated DCS flow-oximeter system for monitoring head/neck 
tumor hemodynamics during radiation delivery. (a) A DCS flow-oximeter was placed 
away from the rotation plane of x-ray beams in the treatment room. (b) A fiber-optic 
probe connected with the DCS flow-oximeter was fixed on the surface of cervical tumor 
node using a pre-molded plastic mask. (c) A computer in the monitoring/control room 
was used to remotely operate the DCS flow-oximeter in the treatment room. 
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4.2.2 DCS Flow-Oximeter 
Tumor blood flow and oxygenation changes during radiation delivery were 
monitored by a DCS flow-oximeter once a week over the 7-week treatment period. 
Details about the DCS flow-oximeter (see Fig. 4.1a) can be found in Chapter 2. The 
oxygenation information is obtained by recording the light intensities at two wavelengths 
(785 and 854 nm) [69, 85, 87, 97]. Δ[HbO2] and Δ[Hb] changes relative to their baseline 
values before treatment are calculated using the modified Beer-Lambert Law [136]. The 
extinction coefficients are determined based on the literature [137, 138] and DPF values 
are calculated using Eq (2A.35).  
4.2.3 Remotely-Operated Optical Measurements during Radiation Delivery  
A customer-designed fiber-optic probe was taped on the surface of the 
radiologically/clinically involved cervical lymph node (see Fig. 4.1b) using Elastikon 
tape (Johnson & Johnson Inc., USA) for tumor blood flow and oxygenation 
measurements. The optical probe consisted of source and detector fibers (at a separation 
of 2.5 cm) whose tips were bent 90º and held by a soft-foam pad. The nonmetallic optical 
fibers and the soft-foam pad are low-density, low atomic number materials which have 
negligible attenuation effects on the x-ray beam. A standard head/shoulder plastic 
immobilization mask (WFR/Aquaplast Corp., USA) was molded around the pre-
positioned optical probe to ensure proper probe placement during subsequent treatment 
sessions (see Fig. 4.1b). The optical probes and DCS flow-oximeter device were kept 
inside the treatment room during radiation delivery and the laptop console was remotely 
operated by a computer located in the monitoring/control room (see Fig. 4.1c). The two 
computers worked under the “Remote Desktop Connect” mode in the Microsoft 
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Windows Operating System and communicated through the internal network in the clinic. 
Using this real-time monitoring system, the optical measurements can be precisely timed 
with the presence or absence of the X-ray beam.  
From the early optical measurements in some patients, abnormal values of β (> 
0.5) and αDB were observed for some X-ray beam positions. The occurrence of the 
artifacts depended on the angle of the X-ray beams as well as the location of optical 
device. We suspect that scattered X-rays were interacting directly with the photodiodes 
generating spurious signals. These signal perturbations were apparently responsible for 
the measurement artifacts in autocorrelation functions. To confirm the source of these 
artifacts, phantom tests were performed (see Section 4.2.4) under the same radiation 
conditions used for the patient treatments. 
4.2.4 Phantom Tests to Identify Optical Measurement Artifacts 
Tissue-like liquid phantoms have been commonly used for instrument calibration 
and experimental validation of DCS techniques [58, 111, 139, 140]. For this study, the 
experimental phantom was prepared by filling a cylindrical tank with the mixture of 
distilled water, India ink (Black India 44201, Higgins, USA) and Intralipid (Fresenius 
Kabi, Sweden). India ink was used to determine the absorption coefficient µa while 
Intralipid provided particle Brownian motion (flow) and control of the reduced scattering 
coefficient µs’. We set µa = 0.12 cm
-1
 and µs
’
 = 8 cm
-1 
at 785 nm to mimic the property of 
real tissues [111]. The Intralipid phantom provided a homogeneous tissue model with 
controlled optical properties and constant particle flow, which should not be changed by 
the x rays. In addition, using tissue phantom can avoid some other potential artifacts (e.g., 
motion artifacts) that may occur in the patient measurements [86]. 
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The set up for the phantom test was similar to that for patient measurements 
shown in Fig. 4.1, except that the patient was replaced with the liquid phantom contained 
by a cylindrical tank. During the beam-on interval, the x-ray beam was turned on 
continually and rotated around the liquid phantom over 360 degrees. The fiber-optic 
probe was secured in contact with the phantom surface using a customer-designed holder. 
The DCS flow-oximeter device was set up in two locations inside the treatment room; 
one was close to the x-ray beam plane so that the optical device was subjected to a 
significant fluence of scattered x rays and another was several meters away from the x-
ray beam plane. This arrangement approximated the two extreme positions in a typical 
patient treatment delivery. The radiation beam energy (6 MV) used for the phantom tests 
was same for the patient treatments (see Section 4.2.3). 
4.2.5 Data Analysis 
Patients were classified into two groups based on clinical outcomes: a complete 
response (CR) group and an incomplete response (IR) group with remote metastasis 
and/or local recurrence within one year. Although 53 patients were measured, 40 patients 
with one-year follow-up results are included in data analysis, among which 12 patient 
data were excluded for data analysis as their optical measurements thought to be 
contaminated by scattered x rays, one patient withdrew from this study at request of the 
patient and one patient was not willing to undergo measurements during radiation 
delivery. The data exclusion of the 12 patients was based on the abnormal β value (> 0.5). 
Details about the tumors, optical measurements (without artifacts), and treatment 
outcomes of the 26 patients are listed in Table 4.1. Patients with unknown primary 
cancers (#18 and #20) were treated as head/neck cancers based on nodal stage of disease 
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with primary origin suspected in the tonsil or the base of tongue. The Response 
Evaluation Criteria in Solid Tumors (RECIST) [141] were used to define the tumor 
response to chemo-radiation therapy. The optical measurements over the entire treatment 
course were not always available for each individual due to the patient related events 
such as side effects of treatment, fatigue, non-compliance with chemo-radiation regimen 
or due to time constraints of obtaining measurements and modification of treatment 
schedules as a consequence of temporary breakdown in radiation therapy equipment. 
Table 4.1 Characteristics of patients/tumors, optical measurements, and treatment 
outcomes 
Pat. 
No 
Primary 
site 
TNM Age Sex Tumor node 
volume(cm3) 
p16 
status 
Data 
availability 
(during-
treatment) 
Data 
availability 
(pre-
treatment) 
Treatment 
outcome 
1 Tonsil T3N2cM0 64 M 68.36 positive E A CR 
2 BOT T3N2cM0 63 F 2.97 negative E A IR 
3 Tonsil T1N3M0 52 M 94.08 positive E A CR 
4 Pyriform 
Sinus T3N2cM0 54 M 70.31 negative E A IR 
5 Tonsil T3N2bM0 69 M 10.21 positive E A IR 
6 BOT T4aN2cM0 72 M 17.40 positive E A CR 
7 Tonsil T3N2bM0 67 M 10.80 NA E A CR 
8 Tonsil T0N2bM0 41 M 29.65 NA E A CR 
9 Tonsil T4aN2cM0 58 M 37.20 positive E A IR 
10 BOT T4aN2cM0 59 M 3.54 positive E A CR 
11 BOT T4aN2bM0 62 F 1.25 negative E NA CR 
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12 Tonsil T2N2cM0 69 M 32.60 positive E NA CR 
13 Tonsil T2N2cM0 67 M 34.00 negative A NA IR 
14 BOT T3N2cM0 64 M 57.90 positive A NA IR 
15 BOT T1N2bM0 67 M 27.00 positive A NA CR 
16 BOT T2N2cM0 62 M 90.00 positive A A IR 
17 Tonsil T1N2bM0 58 M 24.00 positive A A CR 
18 Unknown TxN3M0 67 M 18.00 negative A A CR 
19 BOT T2N2cM0 53 M 28.00 positive A A CR 
20 Unknown TxN2bM0 53 M 14.60 NA A A CR 
21 Larynx T4aN2aM0 66 M 44.10 negative A A CR 
22 BOT T3N2cM0 74 M 14.00 negative A A CR 
23 Larynx T3N2cM0 55 M 16.00 negative A A CR 
24 Tonsil T4aN2cM0 50 M 75.60 positive A A IR 
25 Tonsil T4aN2cM0 70 M 51.40 positive A A IR 
26 BOT T4aN2cM0 60 M 80.14 negative A A CR 
27 Larynx T4aN2cM0 60 F 13.68 positive A A CR 
28 
Tonsil T3N2bM0 48 M 18.56 positive A A CR 
29 BOT T3N2bM0 56 M 17.61 positive NA NA IR 
30 Tonsil T1N2bM0 58 M 96.00 positive A A CR 
31 BOT T0N2bM0 51 F 7.20 NA A A CR 
32 Tonsil T4aN2bM0 59 M 70.10 positive A A CR 
33 BOT T4aN2bM0 60 M 38.10 positive A A CR 
34 Larynx T3N2cM0 49 M 65.30 negative A A CR 
35 BOT T2N2bM0 63 M 35.20 positive A A IR 
36 Larynx T1N2cM0 63 F 4.51 negative A A IR 
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37 Tonsil T3N3M0 50 M 221.90 positive NA A IR 
38 Larynx T3N2cM0 51 F 38.88 negative A A IR 
39 Larynx T2N2cM0 55 M 19.66 negative A A CR 
40 Tonsil T4aN2cM0 58 M 127.92 positive A A CR 
Abbreviations: Pat. = Patient, M: male, F: female, BOT = Base of Tongue, TNM = Tumor, Node, and Metastasis stage, A = Data 
Available, E = Data Excluded (data contaminated by artifacts), NA = Data Not Available, CR = Complete Response, IR = Incomplete 
Response 
Since DCS flow signals are not sensitive to variation in the wavelength [85, 111], 
blood flow data obtained from one wavelength (785 nm) are presented in this study. The 
time courses of blood flow and oxygenation data are normalized to their baseline values 
right before the radiation delivery, respectively. More specifically, rBF represents the 
blood flow change relative to its baseline (assigned to be “1”), and the Δ[HbO2] and 
Δ[Hb] are the dynamic changes in oxygenated and deoxygenated hemoglobin 
concentrations relative to their baselines (assigned to be “0”). The rBF, Δ[HbO2] and 
Δ[Hb] during the fractional radiation deliveries (beam-on intervals) or between the 
fractional deliveries (beam-off intervals) are averaged separately for assessing the instant 
response to radiation delivery in each individual. The averaged hemodynamic changes 
over patients at multiple weeks generate the dynamic variation trends of rBF, Δ[HbO2] 
and Δ[Hb] over the treatment period. The average hemodynamic responses over subjects 
are presented as means ± standard errors (error bars) in figures. For statistical analyses, 
significance is tested using the paired t-test. The criterion for significance is p < 0.05.  
To compare the longitudinal tumor hemodynamic responses between the CR and 
IR groups, we used linear mixed models [142] with fixed effects of time (as categorical), 
CR/IR group, and their interaction and banded covariance structures. Based on the linear 
mixed model for each hemodynamic parameter, an overall test was first constructed to 
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assess whether there were differences in that parameter between the CR and IR groups at 
any time point. In the case of a significant overall test, post hoc pairwise comparisons 
were then conducted at each time point and the Holm's procedure was used to adjust for 
multiple comparisons. A p value less than 0.05 was considered significant.  
4.3. Results 
4.3.1 Phantom Tests 
Figure 4.2 shows the optical measurement data at the wavelength of 785 nm from 
the phantom test when the DCS flow-oximeter was placed close to the x-ray beam plane. 
During the test, the x-ray beam was rotated around the liquid phantom over 360 degrees. 
When the x-ray beam was directed toward the optical device, abnormal correlation curves 
(g2) were obtained (see an example shown in Fig. 4.2a) leading to large increases in β (> 
0.5, see Fig. 4.2b) and αDB (see Fig. 4.2c) as well as slight increases in detected photon 
count rate (see Fig. 4.2d). When the DCS flow-oximeter device was moved away from 
the rotation plane of the x-ray beams, the optical measurements became normal for all 
beam directions. Similar results at the wavelength of 854 nm were also found during the 
phantom test (data are not shown). Notice that in this study β (Fig. 4.2b) and αDB (Fig. 
4.2c) were derived by fitting the measured autocorrelation function curve g2 (Fig. 4.2a), 
as mentioned in Section 4.2.2. However, β  can be also estimated based on the Siegert 
relation using the measured g2 data (Fig. 4.2a) at earliest τ and letting the normalized 
autocorrelation function g1 ≈ 1, i.e., β = g2(τ ≈ 0) - 1 (Fig. 4.2b) [111]. 
 
 
 
70 
 
Figure 4.2 The phantom test results to verify the source of optical measurement artifacts. 
(a) Two autocorrelation curves (g2) were collected at the time points of 117 
(contaminated) and 55 (not contaminated) (sec), respectively. The measured 
autocorrelation curve (empty circles) was contaminated by scattered x rays, resulting in 
an abnormal increase in β. (b) The appearance of abnormal increases in β (> 0.5, empty 
circles) depended on the direction/angle of the radiation beam that rotated 360° around 
the phantom. (c) The x-ray beam induced abnormal increases in relative flow (empty 
circles) derived from the autocorrelation curves. (d) The x-ray beam induced slight 
increases in detected photon count rate (×10
3
 photons/s) (empty circles). 
 
 
Figure 4.3 The in vivo measurement results for the investigation of optical measurement 
artifacts induced by scattered x rays. (a) Three autocorrelation curves (g2) were collected 
at the time points of 417 (contaminated), 99 (slow flow), and 724 (fast flow) (sec), 
respectively. Similar to the phantom test results (see Fig. 4.2a), scattered x-rays 
contaminated the measured autocorrelation curves (empty circles). For the data without 
contaminations (solid circles), the decay rate of autocorrelation curves depended on the 
level of blood flow; g2 decayed faster when blood flow was faster (black solid circles). 
As expected, β (can be estimated using the measured g2 data at earliest τ) was 
independent of blood flow changes when there were no x-ray induced artifacts. (b) 
Scattered x rays created abnormal increases in β (> 0.5, empty circles) depending on the 
direction/angle of radiation beam. (c) The x-ray beam introduced abnormal increases in 
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blood flow (empty circles) derived from the autocorrelation curves. (d) The x-ray beam 
induced minor variations in detected photon count rate (×10
3
 photons/s) (empty circles). 
 
4.3.2 In Vivo Optical Measurements 
Artifacts were also observed in some optical measurements of tumor 
hemodynamics for some x-ray beam directions. Figure 4.3 shows the typical 
contaminated optical data measured at the wavelength of 785 nm during a fractional 
radiation treatment. Similar to the phantom test results, abnormal correlation curves as 
well as the increases in β (> 0.5) and blood flow index (αDB) were observed (see Fig. 
4.3a, 4.3b, and 4.3c) when the optical device was subjected to significantly scattered x 
rays. This effect also induced minor variations in detected photon count rate (see Fig. 
4.3d). Similar artifacts were also observed at the wavelength of 854 nm (data are not 
shown). These results are consistent with the findings from the phantom tests (see Section 
4.3.1). 
After identifying the source of radiation artifacts, we modified the optical 
measurements to minimize these effects. A new fiber-optic probe was constructed using 
the source and detector fibers with a length longer than 5 meters. The optical device 
connected with the new probe was placed approximately 3 meters from the rotation plane 
of the x-ray beams. The longer fiber cable allowed the DCS detector assembly to be 
moved much further away from the primary beam plane so that the impact of scattered x 
rays on the detector was minimized. Thereafter, using the new measurement 
configuration no artifacts (i.e., abnormal β and αDB) were observed in the optical data. 
Figure 4.4 shows the typical responses of rBF, Δ[Hb] and Δ[HbO2] during radiation 
delivery measured from one patient (#18) at two different weeks (Week 1 and Week 4). 
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The values of β throughout the treatment period were stable and approximately equal to 
0.5 (see Fig. 4.4a and Fig. 4.4b), indicating no artifacts involved in the optical 
measurements. A gradual increase in rBF was observed at Week 1 (see Fig. 4.4c), but not 
at Week 4 (see Fig. 4.4d). Variations in Δ[Hb] (see Fig. 4.4e and Fig. 4.4f) and Δ[HbO2] 
(see Fig. 4.4g and Fig. 4.4h) were also found at both weeks. There were no obvious 
differences in tumor hemodynamic responses (i.e., rBF, Δ[Hb] and Δ[HbO2]) between the 
intervals of x-ray beam-on and beam-off.  
 
 
Figure 4.4. The in vivo optical measurement results without x-ray induced 
artifacts during radiation delivery from one patient (#6) at Week 1 (left panel) and 
Week 4 (right panel). As expected, β ((a) and (b)) was stable throughout the 
fractional radiation deliveries and independent of blood flow changes. The typical 
responses of rBF ((c) and (d)), Δ[Hb] ((e) and (f)), and Δ[HbO2] ((g) and (h)) 
were continuously monitored by the DCS flow-oximeter during radiation delivery. 
 
4.3.3 Averaged Hemodynamic Responses over Patients 
In this section, our published results based on 11 patients (#13-#23) are firstly 
presented, followed by updated data resulting from the total 26 patients. Figure 4.5 
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shows the averaged dynamic changes in rBF, Δ[Hb], and Δ[HbO2] over the 11 patients at 
different weeks. The numbers of patients with valid optical data (without artifacts) are 
labeled at each week in Fig. 4.5a. On average, there were no significant differences in 
most of the measured hemodynamic variables (i.e., rBF, Δ[Hb], Δ[HbO2]) between the 
intervals of x-ray beam-on and beam-off, except that a small but significant difference in 
Δ[HbO2] (-0.29 ± 0.12 µM, p = 0.03) was observed between the x-ray beam-on and 
beam-off at Week 1 (see Fig. 4.5c). However, the changes in Δ[HbO2] during radiation 
delivery at Week 1 for both beam-on and beam-off were insignificant compared to their 
baseline values, respectively. As a result, the averaged ΔHbO2 changes including both 
beam-on and beam-off data at Week 1 were also insignificant. Therefore, the 
hemodynamic changes were believed to be induced by an accumulated effect of the 
fractional radiation dose over the entire period of radiation delivery. Thus, we calculated 
the individual means of hemodynamic responses (i.e., rBF, Δ[Hb] and Δ[HbO2]) over the 
entire course of radiation treatment including both beam-on and beam-off intervals. The 
calculated average hemodynamic results over the 11 patients are listed in Table 4.2. 
Although variations in rBF during radiation delivery were observed over the 7-week 
treatment period, only the change at the first week (1.11 ± 0.03) were significant (p = 
0.003) compared to its baseline before treatment. By contrast, the variations in both 
Δ[Hb] and Δ[HbO2] over the treatment periods were not statistically significant.  
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Figure 4.5. The averaged dynamic changes in rBF (a), Δ[Hb] (b) and Δ[HbO2] (c) 
over the 11 patients at different weeks. Data obtained during the fractional 
radiation deliveries (beam-on intervals) or between the fractional deliveries 
(beam-off intervals) were averaged separately. A small but significant difference 
in Δ[HbO2] (-0.29 ± 0.12 µM) was observed between the x-ray beam-on and 
beam-off at Week 1 (* represents p < 0.05). 
 
Table 4.2 Overall changes (means ± standard errors) in rBF, Δ[Hb] and Δ[HbO2] over 11 
patients at different weeks 
Week 1 2 3 4 5 6 7 
Number of patients 11 9 5 5 3 5 4 
rBF 
1.11 ± 
0.03** 
1.04 ± 
0.03 
1.07 ± 
0.06 
1.03 ± 
0.05 
1.13 ± 
0.12 
1.05 
± 
0.04 
1.06 
± 
0.04 
Δ[Hb] (µM) 
-0.96 ± 
1.66 
0.91 ± 
1.00 
1.82 ± 
0.58 
1.77 ± 
0.97 
0.05 ± 
1.10 
0.71 
± 
0.92 
-0.21 
± 
1.02 
Δ[HbO2] (µM) 
-0.44 ± 
0.70 
0.00 ± 
0.69 
-0.36 
± 1.07 
-0.97 
± 0.87 
0.67 ± 
0.54 
1.66 
± 
0.85 
1.46 
± 
2.14 
∗∗ represents p < 0.01. 
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Figure 4.6 Averaged values (means ± standard errors) of rBF, Δ[Hb] and Δ[HbO2] in 26 
patients at different weeks. Overall changes in 26 patients (left panel, (a), (c), (e)) and 
changes in patients grouped by incomplete response (IR) and complete response 
(CR)graoup (right panel, (b), (d), (f)). The numbers shown at each week represent the 
valid measurements in all patients, respectively. ∗ represents p < 0.05 and ∗∗ represents p 
< 0.01. 
 
Figure 4.6 shows the updated results of the 26 patients. Overall on average (n = 
26, see the left panel in Fig. 4.6), we observed significant changes in rBF at the first two 
weeks (1.13 ± 0.03 and 1.10 ± 0.04; p = 0.0006 and 0.03) compared to its baseline values 
before the treatment. Only the changes in Δ[Hb] at the Week 3 (1.18 ± 0.40 µM) were 
significant (p = 0.01) compared to its baseline value before the treatment.  
However, after breaking down the patients into subgroups of CR and IR groups 
and testing global difference with linear mixed model, no overall significant difference 
was found in rBF, Δ[Hb] and Δ[HbO2] (p = 0.17, 0.55 and 0.41 respectively) between 
these two group (right panel in Fig. 4.6).  
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4.4. Discussion and Conclusions 
Although NIR diffuse optical techniques have been used as bedside monitoring 
tools in many clinical studies [65, 83, 88, 91, 143-153], they have not been applied to 
patients inside radiation treatment room. The challenges to adapt the optical techniques 
for use during radiation delivery include installing the optical probe properly on the 
surface of tumor node, operating the optical device from a separated control room, and 
avoiding the potential interference between the scattered X rays and optical 
measurements.  
In the present study several crucial steps were taken to adapt the DCS flow-
oximeter for the use of monitoring tumor blood flow and oxygenation during radiation 
delivery. A pre-molded plastic mask was made to hold the optical probe in a proper 
contact with the tumor nodal mass (see Fig. 4.1a and Fig. 4.1b) throughout the treatment 
period for reducing the motion artifacts to optical measurements. Two computers located 
separately in the treatment and control rooms communicated through the internal 
network, enabling to remotely operate the DCS flow-oximeter (see Fig. 4.1c). Finally, 
tissue phantom tests were conducted to determine the source of optical measurement 
artifacts (i.e., abnormal β and αDB) observed in the patient measurements during radiation 
delivery.  
As described early in Section 3.2.2, β depends mainly on the detection optics, and 
the maximum β value should be ∼0.5 when using a single-mode fiber to detect the 
speckle fluctuations [140]. However, abnormal high values of β (> 0.5) were observed 
during radiation delivery in both phantom (see Fig. 4.2) and patient (see Fig. 4.3) 
measurements when the optical device was placed close to the rotation plane of x-ray 
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beams. When the DCS flow-oximeter device was moved away from the x-ray beams, the 
optical measurements became normal throughout the entire treatment period (see Fig. 
4.4). These findings suggest that the observed artifacts were generated by the scattered X 
rays interacting directly with the optical detector and they can be eliminated by simply 
moving the optical device (detector) away from the radiation beams.  
After moving the optical device out of the X-ray beams, we have successfully 
collected valid optical data (without artifacts) from 26 patients during x-ray delivery. 
Large inter-patient variations in tumor hemodynamic responses were observed during 
radiation delivery (see the large error bars in Fig. 4.5). On average (see Table 4.2 and 
Fig. 4.6), a significant increase in tumor blood flow during radiation delivery was 
observed at the first two weeks of treatment, which may be a physiologic response to 
hypoxia created by radiation oxygen consumption. Similar increases in blood flow were 
previously observed in tumors during the early period of PDT delivery [65]. This 
regulation ability in blood flow seemed to decline with the progress of weekly treatments. 
Interestingly, only small and insignificant changes were found in tumor blood 
oxygenation (Δ[Hb] and Δ[HbO2]) during radiation delivery over the 7-week treatment 
period (see Table 4.2). The absence of substantial tumor oxygenation changes suggested 
that oxygen utilizations in tumors during the short period of fractional radiation deliveries 
(3 to 4 minutes) were either minimal or balanced by other effects such as blood flow 
regulation.  
The increase in rBF can reduce the tumor [Hb] level at the first two weeks but 
with treatment progress, the loss of blood flow regulation ability leads to an increase 
trend in Δ[Hb] and a decrease trend in Δ[HbO2]. Clarification of the reasons for limited 
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oxygenation changes during radiation delivery will require separate investigations. 
Oxygenation changes during radiation therapy may be due to the reassortment of the cells 
in the cell cycle, revascularization, repopulation of the tumor cells and cell kill. As these 
issues were not being measured it is outside the purview of the present study. 
No overall significant difference was found in rBF, Δ[Hb] and Δ[HbO2] between 
CR and IR groups (right panel in Fig. 4.6), suggesting insignificant influences of these 
factors on measurement/treatment outcomes with small variations of these parameters in 
very short treatment time.  
Although there is much work to be done, our pilot study results suggest that tumor 
hemodynamic changes during radiation delivery can be optically detected using the DCS 
flow-oximeter without being overly burdensome on patients. The unique remotely 
operated optical system developed in this study has potential to be used in other 
therapeutic/diagnostic rooms (e.g., CT) where operators are not allowed to stay. 
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CHAPTER 5 DIFFUSE OPTICAL MEASUREMENTS OF HEAD AND NECK 
TUMOR HEMODYNAMICS FOR EARLY PREDICTION OF CHEMO-
RADIATION THERAPY OUTCOMES 
5.1 Introduction 
Near-infrared (NIR) diffuse optical methods offer a noninvasive, portable, fast, 
and low-cost alternative for frequently monitoring tumor microvascular hemodynamics at 
the bedside over the time course of treatment [65, 83, 88, 91, 143-153]. For example, 
Sunar et al previously used a hybrid NIR diffuse optical instrument for noninvasive 
measurements of tumor hemodynamic responses to chemo-radiation therapy in a small 
group of patients with head and neck tumor [88]. Tumors exhibited significant flow and 
oxygenation changes during the first four weeks of the treatment. However, their study 
was limited by the small number of patients examined (n = 8) and only one patient out of 
8 showed a partial response to the treatment. It was therefore difficult to draw a 
conclusion from this pilot study about the feasibility of measuring tumor hemodynamics 
for predicting treatment outcomes [88]. 
Our study aimed to investigate prognostic values of hemodynamic measurements 
in head and neck tumors during chemo-radiation therapy for predicting treatment 
responses. For this purpose, we developed a novel hybrid diffuse optical instrument 
combining a commercial frequency-domain tissue oximeter (Imagent, ISS Inc., IL) and a 
custom-made diffuse correlation spectroscopy (DCS) flowmeter, which allowed for 
simultaneous measurements of tumor blood flow and blood oxygenation [85, 111, 134]. 
The clinically involved cervical lymph nodes were measured by this hybrid instrument 
once a week over the treatment period of 7 weeks. A linear mixed model was then 
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applied to investigate the sensitivity and specificity using early tumor hemodynamic 
responses to therapy to predict one-year treatment outcomes. 
5.2 Methods and Materials 
5.2.1. A Hybrid Diffuse Optical Instrument for Continually Monitoring Tumor 
Hemodynamics 
Our hybrid diffuse optical instrument combining a commercial NIR tissue-
oximeter (Imagent, ISS, IL) and a custom-built DCS flowmeter allows us to measure 
simultaneously tumor blood flow and blood oxygenation (Fig. 2.3). For this study, we 
built a hybrid fiber-optic probe by adding the source and detector fibers for DCS 
measurement onto the Imagent probe (Fig. 2.3b). As mentioned earlier, the S-D distances 
for DCS and Imagent were 2.5 cm and 2.0 to 3.5 cm respectively, allowing for the 
detection of a tumor larger than 2 cm in size. Computer-controlled transistor-transistor 
logic (TTL) signals were used to control the Imagent and DCS devices working 
alternately; lasers for DCS and Imagent measurements were turned on sequentially to 
avoid the light interference between the two measurements (Fig. 2.3a). The sampling 
time for a complete frame of blood flow and oxygen measurements was ~4 seconds (0. 
25 Hz).  
Our previous investigations have revealed that µa and µs’ can significantly affect 
the accuracy of DCS flow quantifications [111, 134]. Thus, μa and μs’ measured by the 
Imagent at 780 nm (close to the 785 nm laser used for DCS flow measurements) were 
used as inputs for calculating BFI (see Fig. 2.3a). The final outputs from this hybrid 
instrument included µa, µs’, [HbO2], [Hb], THC, StO2, and BFI.  
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5.2.2. Patient Characteristics and Treatment Protocol 
Fifty-three patients (n = 53) with head and neck tumors undergoing chemo-
radiation therapy participated in this study with the signed consents approved by the 
University of Kentucky Institutional Review Board. Based on the detection limitation in 
tumor size for optical measurements, we included Stage III-IVb SCCHN with a cervical 
tumor node larger than 2 cm in the longitudinal dimension. Tumor location and size were 
identified by MRI, CT and/or ultrasound imaging. Patients with supraclavicular 
adenopathy were not enrolled as there was a possibility of the primary origin from other 
sites in the chest such as lung or esophagus.   
Each patient received daily fractional radiation over 7 weeks. A total dose of 70 
Gy was delivered in once daily fractions of 2 Gy, and in the form of high-energy X-ray 
beams (6 MV) produced by a medical linear accelerator (Clinac 21EX, Varian Medical 
Systems, USA). Radiotherapy in combination with traditional chemotherapy was applied 
on these patients. The cisplatin was given at 100 mg/m2 on Day 1 and Day 22 of 
radiation. The role of chemotherapy (cisplatin) in head/neck cancer was to increase the 
incidence of double strand breaks (radiosensitization) and decrease the incidence of 
metastatic diseases.  
 5.2.3. Experimental Protocols 
Prior to treatment, clinical exams of HPV-16 status and hemoglobin concentration 
of blood samples were collected. The biggest clinically involved cervical lymph node 
was identified by MRI or CT imaging as the measured target and then the tumor node 
volume and location were quantified. The optical measurement protocol consisted of a 
pre-treatment measurement as baseline and weekly measurements (once per week) over 
 
 
82 
the entire treatment period of 7 weeks (Fig. 5.1a). Before each measurement, an 
ultrasound machine (Mindray M5, Mindray, China) was used to verify the location and 
size of the tumor node. The Imagent was calibrated using a solid phantom with known 
optical properties (µa and µs’).  
The optical measurement was then continuously taken by placing the hybrid fiber-
optic probe on the surface of the selected lymph node (Fig. 5.1b) for 3 minutes with a 
sampling rate of 0.25 Hz, followed by taking a measurement on the forearm flexor 
muscle for 2 minutes as a control for comparison. Data obtained over the measurement 
period were averaged and mean values were used to represent tumor optical properties 
and hemodynamics. 
Clinical outcome assessments such as tumor volume change, local control, remote 
metastasis, and/or local recurrence were conducted every three months after completing 
the chemo-radiation therapy.  
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Figure 5.1 Measurement setup and protocol: (a) chemo-radiation therapy protocol and 
measurement procedures and (b) optical measurement (left) using a hybrid Imagent/DCS 
instrument (right). 
 
5.2.4 Data Analysis and Presentation 
Table 5.1 Patient/tumor characteristics based on HPV-16 status and treatment outcomes 
 
 All Patients HPV-16 Positive 
Patients 
HPV-16 Negative 
Patients 
CR 
Patients 
IR 
Patients 
Age       
mean ± SE (yrs) 58.59 ± 1.28 59.11 ± 1.50 59.73 ± 2.20 58.22 ± 
1.60 
59.36 ± 
2.09 
Gender      
Male 29 (3*) 18 8 21 8 
Female 5 (1*) 1 3 2 3 
Hemoglobin       
mean ± SE (g/dL) 13.94 ± 0.27 14.03 ± 0.37 13.64 ± 0.46 14.18 ± 
0.34 
13.43 ± 
0.39 
Primary Tumor Site      
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Base of tongue 10 (1*) 6 3 7 3 
Larynx 8 1 7 5 3 
Tonsil 14 (2*) 12 0 9 5 
Unknown primary 2 (1*) 0 1 2 0 
Tumor Stage      
Tx + T0-2 12 (3*) 6 3 9 3 
T3-4 22 (1*) 13 8 14 8 
N stage      
N1 0 0 0 0 0 
N2-3 34 (4*) 19 11 23 11 
Tumor Node Size      
mean ± SE  (cm3) 23.98 ± 3.97 30.90 ± 6.16 17.80 ± 4.14 20.93 ± 
3.67 
30.38 ± 
9.26 
Cutaneous Tissue Thickness        
mean ± SE (mm) 11.71 ± 1.13 12.17 ± 1.28 10.73 ± 2.63 11.70 ± 
0.97 
11.75 ± 
2.84 
* indicates the number of patients without testing HPV-16 status. 
Patients were classified into two groups based on clinical outcomes: a complete 
response (CR) and an incomplete response (IR) group with the remote metastasis and/or 
local recurrence within one year after radiation therapy. Although 53 patients were 
measured, so far only 40 patients have one-year follow-up treatment outcome results. 
Among these 40 patients, one was withdrawn from study at request of the patient and five 
did not have pretreatment measurements due to instrument issues. Therefore, 34 patients 
were included in our data analysis (see Table 5.1). The optical measurements over the 
entire treatment courses of 7 weeks were not always available for each individual due to 
patient-related issues such as side effects of treatment, fatigue, non-compliance with 
chemo-radiation regimen or due to time constraints of obtaining measurements and 
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modification of treatment schedules as a consequence of temporary breakdown in 
radiation therapy equipment. Therefore, we marked the number of valid measurements at 
each week in figures. Data obtained beyond 4 weeks of the treatment were also excluded 
because majority of tumor nodes became too small (due to radiation therapy) to be 
visible/measurable by the optical technique.  
Student's t tests were used to compare the differences between groups in age, 
pretreatment hemoglobin level in blood sample, tumor node size, and cutaneous tissue 
thickness above the tumor (Table 5.1). The criterion for significance was p < 0.05. 
To compare the time course tumor hemodynamic responses to therapy between 
the CR and IR groups and between HPV-16 positive and HPV-16 negative groups, we 
used linear mixed models [142] with fixed effects of time (as categorical), group (CR/IR 
or HPV-16 positive/HPV-16 negative), and their interaction and banded covariance 
structures. Based on the linear mixed model for each hemodynamic parameter, an overall 
test was first constructed to assess whether there were differences in that parameter 
between groups at any time point. In the case of a significant overall test, post hoc 
pairwise comparisons were then conducted at each time point and the Holm's procedure 
was used to adjust for multiple comparisons. A p value less than 0.05 was considered 
significant.  
The predictive values of different optical measurements can vary over time. 
Receiver operating characteristic (ROC) curves were constructed and the areas under the 
ROC curves (AUC) were calculated to evaluate the abilities of various diffuse optical 
parameters at different weeks for discriminating the CR and IR groups. The bootstrap 
method [154] with 500 bootstrap samples was used to obtain the 95% confidence interval 
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(CI) of the AUC. A 95% CI of AUC not including 0.5 indicates a significant result. The 
statistical analyses were performed by SAS 9.3 and R software version 3.0.1. 
Particularly, the ROCR package was used to calculate the AUC. 
5.3 Results 
The differences in tumor hemodynamic responses to chemo-radiation therapy 
between the IR and CR groups were firstly compared without considering the effects of 
HPV-16 status (Section 5.3.1). We then refined comparisons by separating patients to 
HPV-16 positive group or HPV-16 negative group, and reported the results in Section 
5.3.2 and Section 5.3.3, respectively. Based on these results, we summarized prognostic 
values of the measured parameters for one-year treatment outcomes (Section 5.3.4). 
Finally, we compared the differences in tumor hemodynamic responses and treatment 
outcomes between the HPV-16 positive and HPV-16 negative groups (Section 5.3.5).  
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5.3.1 Overall Tumor Responses to Therapy without Considering HPV-16 Status 
 
Figure 5.2 Averaged values (means ± standard errors) of hemodynamic and diffuse 
optical parameters in tumor nodes without considering HPV-16 status grouped by 
incomplete response (IR) and complete response (CR): (a) blood flow index (BFI or 
αDB), (b) oxygenated hemoglobin concentration ([HbO2]), (c) total hemoglobin 
concentration (THC), (d) reduced scattering coefficient (μs’), (e) deoxygenated 
hemoglobin concentration ([Hb]), and (f) blood oxygen saturation (StO2) in tumor nodes 
at different weeks. Note that p-values derived from the linear mixed-effects model for 
overall differences between the IR and CR groups are shown. The numbers shown at 
each week represent the valid measurements in IR and CR patients, respectively. 
 
Figure 5.2 shows the dynamic changes of optical properties and tissue 
hemodynamics over the treatment period of the first 4 weeks, measured in the tumor 
nodes without considering HPV-16 status. Overall, there were significant differences in 
[HbO2] and StO2 between the IR and CR groups (p = 0.04 and 0.01, respectively). 
However, post hoc pairwise tests didn’t find any significant difference in any parameter 
at any measurement time point between the two groups.  
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For control measurements in forearms, no significant difference in either overall 
the treatment period or at any time measurement time point was found between the two 
groups (data are not shown). There were no significant baseline differences prior to the 
treatment in age, hemoglobin level of blood sample, tumor node size, and cutaneous 
tissue thickness above the tumor between the CR and IR groups (Table 5.1). 
5.3.2 Comparison of Tumor Hemodynamic Responses between IR and CR Groups in 
HPV-16 Positive Patients 
 
Figure 5.3 Averaged values (means ± standard errors) of hemodynamic and diffuse 
optical parameters in HPV-16 positive patients grouped by IR and CR: (a) BFI (αDB), (b) 
[HbO2]), (c) THC, (d) μs’, (e) [Hb], and (f) StO2 in tumor nodes at different weeks. Note 
that p-values derived from the linear mixed-effects model for overall differences between 
the IR and CR groups are shown. The numbers shown at each week represent the valid 
measurements in IR and CR patients, respectively. Significant differences at 0.01 and 
0.05 levels between groups derived from pairwise comparisons at different time points 
are indicated with ** and * respectively. 
 
Dynamic changes of optical properties and tissue hemodynamics in tumor nodes 
of HPV-16 positive patients in response to therapy are summarized in Fig. 5.3. Overall, 
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there were significant differences in [HbO2] (Fig. 5.3b), THC (Fig. 5.3c), and StO2 (Fig. 
5.3f) between the IR and CR groups (p = 0.003, 0.03, 0.01, respectively). Post hoc 
pairwise tests demonstrated that the IR group had significant lower levels in [HbO2] at 
Week 1 (Fig. 5.3b) and StO2  at Week 3 (Fig. 5.3f) at Week 1 and Week 3, respectively, 
compared to the CR group (p = 0.02 and 0.03 respectively).  
In HPV-16 positive patients, only forearm StO2 in the IR group showed an overall 
significantly lower level than the CR group (p = 0.04, data are not shown). However, post 
hoc pairwise tests didn’t find any significant difference in forearms at any measurement 
time point between the two groups. 
5.3.3 Comparison of Tumor Hemodynamic Responses between the IR and CR Groups in 
HPV-16 Negative Patients 
 
Figure 5.4 Averaged values (means ± standard errors) of hemodynamic and diffuse 
optical parameters in tumor nodes in HPV-16 negative patients grouped by incomplete 
response (IR) and complete response (CR): (a) BFI (αDB), (b) oxygenated hemoglobin 
concentration ([HbO2]), (c) total hemoglobin concentration (THC), (d) reduced scattering 
coefficient (μs’), (e) deoxygenated hemoglobin concentration ([Hb]), and (f) blood 
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oxygen saturation (StO2) in tumor nodes at different weeks. Significant differences at 
0.01 and 0.05 levels between groups derived from pairwise comparisons at different time 
points are indicated with ** and * respectively. 
 
Figure 5.4 shows the dynamic changes of optical properties and tissue 
hemodynamics in tumor nodes in response to therapy in HPV-16 negative patients. 
Overall, there were significant differences in BFI (Fig. 5.4a) and μs’ (Fig. 5.4d) between 
the two groups (p = 0.007 and 0.0005, respectively). Post hoc pairwise tests demonstrated 
that the mean BFI at Week 3 (p = 0.0007) and μs’ at Week 3 and Week 4 (p = 0.01 and 
0.03 respectively) in the IR group were significantly higher than those in the CR group. 
For the control measurements in forearms, no significant difference in either 
overall treatment period or at any measurement time point was found between the two 
groups (data are not shown). 
5.3.4 Time-Specific Receiver Operating Characteristic Curves for Predicting Treatment 
Outcomes 
Table 5.2 Summary of time-specific AUC estimates (95% confidence interval) of the 
measured parameters for the prediction of treatment outcomes in HPV-16 
positive/negative patients 
 Baseline Week 1 Week 2 Week 3 Week 4 
HPV-16 Positive Patients 
   [HbO2] 0.54 (0.25, 0.82) 0.93 (0.72, 1.00) 0.82 (0.56, 1.00) 0.82 (0.57, 1.00) 0.67 (0.24, 1.00) 
   StO2 0.61 (0.27, 0.90) 0.80 (0.52, 1.00) 0.69 (0.35, 0.96) 0.85(0.56, 1.00) 0.63 (0.23, 0.97) 
HPV-16 Negative Patients 
   BFI 0.54 (0.13, 0.89) 0.62 (0.25, 0.98) 0.75 (0.40, 1.00) 1.00 (1.00, 1.00) 0.67 (0.17, 1.00) 
   μs’ 0.82 (0.52, 1.00) 0.91 (0.63, 1.00) 0.83 (0.50, 1.00) 0.95 (0.75, 1.00) 0.87 (0.57, 1.00) 
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Figure 5.5 Receiver operating characteristic curves (ROC) and their associated areas 
under the curve (AUC) for discriminating tumors with incomplete or complete responses. 
(a) [HbO2] at Week 1 in HPV-16 positive patients, (b)  StO2 at Week 3 in HPV-16 
positive patients, (c) BFI in HPV-16 negative patients at Week 3 and (d) μs’ in HPV-16 
negative patients at Week 3. 
 
To evaluate the predictive values of hemodynamic parameters over the treatment 
period, we calculated time-specific ROC curves utilizing optical measurements obtained 
at different weeks. Table 5.2 and Fig. 5.5 summarize the ROC results for the parameters 
showing predictive ability to differentiate IR tumors from CR tumors. The results 
underlined in the table are considered to have good predictive ability for treatment 
outcomes. Figure 5.6 shows representative ROC curves for discriminating tumors with 
incomplete or complete responses. 
In HPV-16 positive patients, [HbO2] provided the best prediction of treatment 
outcomes at Week 1 (AUC = 0.93 [95% CI: 0.72-1.00]). StO2 also showed a moderate 
prediction of treatment outcomes at Week 3 (AUC = 0.85 [95% CI: 0.56-1.00]). In HPV-
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16 negative patients, BFI and μs’ provided excellent predictions of treatment outcomes at 
Week 3 (AUC = 1.00 [95% CI 1.00-1.00] and 0.95 [95% CI 0.75-1.00] respectively). In 
particular, μs’ values over the  first 4 weeks of treatment period demonstrate consistent 
predictive ability for treatment outcomes. 
5.3.5 Comparisons of Tumor Hemodynamic Responses between the HPV-16 Positive 
Group and HPV-16 Negative Group 
There were no significant baseline differences prior to the treatment in age, 
hemoglobin level of blood sample, tumor node size, and cutaneous tissue thickness above 
the tumor between the HPV-16 positive group and HPV-16 negative group (Student t 
tests in Table 5.1). Overall, there were no significant differences in all measured optical 
parameters between the two groups, tested by the linear mixed models (data are not 
shown). 
5.4 Discussion and Conclusions  
This study aimed to test the sensitivity and specificity of tumor hemodynamic 
parameters for early prediction of chemo-radiation therapy outcomes in patients with 
head and neck cancer. We utilized a novel hybrid diffuse optical instrument developed in 
our laboratory and measured dynamic changes in tumor optical properties and 
hemodynamics weekly over the treatment period. We examined the predictive values of 
multiple parameters measured in local tumors including BFI, μs’, [HbO2], [Hb], THC, 
and StO2 in relation to one-year treatment outcomes. In addition, we also collected other 
information about the patients including ages, tumor volumes, hemoglobin levels in 
blood samples and hemodynamic changes in forearm muscles over the treatment period. 
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No significant baseline differences prior to the treatment in age, hemoglobin level 
of blood sample, tumor node size, and cutaneous tissue thickness between the CR and IR 
groups (see Table 5.1), suggesting insignificant influences of these factors on treatment 
outcomes. Forearm hemodynamics didn’t show a significant difference at any 
measurement time point between the CR and IR groups, indicating insignificant impacts 
of chemo-radiation therapy on tissues outside the radiation beam. 
Based on the overall results from 34 patients, we observed significant differences 
in tumor [HbO2] and StO2 between the IR and CR groups over the treatment period. 
However, post hoc pairwise tests could not find any significant difference at any specific 
measurement time point (see Fig. 5.2). Interestingly, after breaking down the patients into 
subgroups of HPV-16 positive and HPV-16 negative, we found significant differences in 
some  of the measured parameters between the IR and CR groups. 
In HPV-16 positive patients, IR tumors showed significant lower levels of [HbO2] 
and StO2 compared to the CR tumors at Week 1 and Week 3 (see Fig. 5.3). These results 
agree with previous observations that HNSCC with insufficient oxygen has poor 
treatment outcomes [20-29]. 
In HPV-16 negative patients, IR tumors showed a continual increase in BFI and 
consistently higher values in μs’ compared to CR tumors over the first 4 weeks of the 
treatment period (see Fig. 5.4); significant higher levels in BFI at Week 3 and μs’ at 
Week 3 and Week 4 were observed in IR tumors. These results are consistent with some 
reported findings. Previously, high angiogenesis has been found to be related to poor 
local control rate in head and neck cancers under radiation therapy [155, 156]. Dynamic 
blood flow increases during radiation therapy have also been observed in head and neck 
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tumors with incomplete responses [88, 157]. The significant higher levels of BFI and μs’ 
in IR tumors may be associated with more active angiogenesis which forms defective 
vascular networks, leading to blood leakiness inside tumors and poor efficiency in 
oxygen supply. In addition, a higher blood flow level may be attributed to a higher up-
regulation of vascular endothelial growth factor in IR tumor cells than in CR tumor cells, 
which promotes the survival of endothelial cells and thereby radiation resistance [158]. 
Also, higher expression of endothelial nitric oxide in IR tumors may further enhance 
blood perfusion, open up nonperfused vessels, and promote neoangiogenesis [157, 159].  
In this study we found that different parameters have different sensitivity and 
specificity in predicting treatment outcomes (see Table 5.2 and Fig. 5.5). For example, 
[HbO2] and StO2 show prognostic values for predicting treatment outcomes in HPV-16 
positive patients while  BFI and μs’ provide the best prediction of treatment outcomes in 
HPV-16 negative patients. Although the differences between HPV-16 positive and HPV-
16 negative patients in tumor gene mutations [160], tumor microenvironment [161], 
metabolic profile [162], angiogenesis [163], and adaptation to hypoxia may have impacts 
on treatment outcomes, exact pathogenic mechanisms underlying these differences need 
further investigations.  
In summary, our diffuse optical measurements show great potential for early 
(within the first 3 weeks of treatment period) prediction of chemo-radiation therapy in 
patients with head and neck cancer. Since HPV-16 status affects tumor responses to 
therapy, subgrouping patients based on HPV-16 status can improve the prediction of 
treatment outcomes. More patients are being recruited to increase statistical power of data 
analysis and for developing a predictive model integrating multiple parameters to 
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improve the sensitivity and specificity of prediction. Ultimately, reduction of side effects 
in patients not benefiting from chemo-radiation therapy may be feasible through early 
predicting the incomplete responses.  
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CHAPTER 6 STUDY SUMMARY, LIMITATIONS, AND FUTURE 
PERSPECTIVES 
In this dissertation, I present study motivation, theoretical background, technical 
development, and clinical application results for longitudinal monitoring of 
hemodynamic responses to chemo-radiation therapy in head and neck tumors using near-
infrared diffuse optical technologies. During the study, I overcome a number of technical 
challenges in adapting our novel hybrid diffuse optical techniques for simultaneous 
measurements of tumor blood flow and oxygenation during chemo-radiation therapy in 
HNSCC. 
My major contributions include: (A) participating in the development of the 
hybrid diffuse optical instrument combining a commercial tissue oximeter (Imagent) and 
custom-made DCS as well as the novel portable dual-wavelength DCS flow-oximeter 
(Chapter 2) [85]; (B) comprehensively investigating the possibility of fitting multiple 
parameters from the measured one single autocorrelation curve of DCS and evaluating 
the accuracy and performance of the two fitting methods with computer simulations, 
tissue-like phantom experiments, and in-vivo tissue measurements (Chapter 3) [134]; (C) 
identifying and overcoming measurement artifacts induced by scattered X-rays and 
applying the remotely controlled DCS flow-oximeter in the treatment room for the first 
continuous measurements of tumor hemodynamic changes during x-ray radiation 
delivery (Chapter 4) [116]; (D) continually monitoring tumor optical and hemodynamic 
status over 7 weeks of treatment period (Chapter 5), and (E) discovering the impacts of 
tumor HPV status on hemodynamic responses to the treatment and quantifying the 
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sensitivity and specificity of multiple hemodynamic parameters for early prediction of 
treatment outcomes in HNSCC (Chapter 5). 
More specifically, we observed a large crosstalk between αDB and μa or αDB and 
μs’, which can greatly affect the accuracy in extracting BFI (αDB) of DCS [111]. My 
study revealed that these paired parameters can compensate each other to generate a 
similar autocorrelation curve (Chapter 3.4). In contrast, β did not compensate the 
variation of αDB and thus simultaneous fitting of β and αDB was feasible and generated 
more accurate estimations of these parameters with smaller standard deviations (Chapter 
3). On the other hand, our hybrid diffuse optical instrument (Imagent/DCS) allowed to 
quantify the absolute values of μa and μs’. Using these optical properties as inputs and our 
novel simultaneously fitting method, β and αDB can be accurately quantified (Chapter 2 
and Chapter 3). Through phantom tests, I found that artifacts caused by scattered x rays 
can be avoided by moving the optical device away from the x-ray beams (Chapter 4). A 
significant increase in tumor blood flow was observed at the first two weeks of treatment 
and only small changes were found in tumor blood oxygenation during radiation delivery 
(Chapter 4). Interestingly, I found that human papilloma virus (HPV-16) status largely 
affected tumor homodynamic responses to therapy and different parameters had different 
sensitivity and specificity in predicting treatment outcomes in HPV-16 positive patients 
or HPV-16 negative patients. By grouping patients according to HPV-16 status, I found 
some of these hemodynamic parameters were sensitive and specific for early 
identification of incomplete responders to chemo-radiation therapy (Chapter 5). 
It should be noted that our results and conclusions should be interpreted with 
caution due to the limited numbers of patients and measurements. More patients are 
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needed to increase the statistical power for data analysis and to develop predictive models 
integrating multiple parameters for better prediction of individual treatment outcomes. 
As described in Chapter 1, assessment of tumor heterogeneity is also potential 
biomarker for tumor characterization and treatment response prediction. The near-
infrared spectroscopies used in this study have the limited spatial resolution. Near-
infrared (NIR) imaging technologies such as diffuse optical/correlation tomography 
(DOT/DCT) [164] should be explored in the future to quantify hemodynamic 
heterogeneity in tumor. 
I expect that with further technology development and large population 
measurements, our hybrid diffuse optical techniques with multiple-parameter outputs will 
provide valuable information for early prediction of radiation therapy outcomes. 
Ultimately, reduction of side effects in patients not benefiting from radiation treatment 
will be feasible.  
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GLOSSARY 
SYMBOLS 
α   Ratio of Dynamic to Static Scatterers (0 - 1) 
ac   Modulated Light Amplitude 
β   Coherence Factor 
c   Hemoglobin Concentration of Whole Blood 
γ   Percentage of Blood Volume Contained in the Venous Compartment 
D   Photon Diffusion Constant 
DB  Effective Diffusion Coefficient 
Φdc   Average Light Intensity 
Φac  Peak-to-peak Light Intensity 
g1   Normalized Electric Field Temporal Autocorrelation Function 
G1   Unnormalized Electric Field Temporal Autocorrelation Function 
g2   Normalized Intensity Temporal Autocorrelation Function 
I   Intensity 
k0   Wavevector of Photons in Medium (k0 = 2π /λ) 
kB  Boltzmann Constant 
λ   Wavelength 
n   Ratio of Sample and Air Index of Refraction 
φ   Phase Shift Between the Detected and Source NIR Light  
ɛ  Extinction Eoeficient 
R·  DNA free radical 
r   Position Vector  
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ρ   Source-detector Separation 
<Δr
2
(τ) >  Mean-square Particle Displacement in Time τ  
SAC   Slope of ρ vs. AC component light intensity Curve 
SDC   Slope of ρ vs. DC component light intensity Curve 
Sφ   Slope of ρ vs. Phase shift Curve 
S0   Source-light Distribution 
τ   Correlation Function Decay Time 
μa   Absorption Coefficient 
μs’   Reduced Scattering Coefficient 
v   Speed of Light in Medium 
ω   Angular Frequency of Modulation 
 
TERMS 
[Hb]  deoxygenated hemoglobin concentration (unit μM) 
[HbO2] oxygenated hemoglobin concentration (unit μM) 
Δ[Hb]  deoxygenated hemoglobin concentration change (unit μM) 
Δ[HbO2] oxygenated hemoglobin concentration change (unit μM) 
ΔTHC  total hemoglobin concentration change (unit μM) 
ADC  Apparent Diffusion Coefficient 
APD   Avalanche Photodiode 
ASL-MRI  Arterial Spin-Labeled Magnetic Resonance Imaging (Perfusion MRI) 
BFI   Blood Flow Index (αDB) 
BF  Blood Flow 
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BOLD-MRI Blood Oxygen Level Dependent Magnetic Resonance Imaging 
BV  Blood Volume 
CR  Complete Response 
CT  Computed Tomography  
CW   Continuous Wave 
DPF  Differential Pathlength Factor 
DCE  Dynamic Contrast-Enhanced 
DCS   Diffuse Correlation Spectroscopy 
DOS  Diffuse Optical Spectroscopy 
DWI  Diffusion-Weighted Imaging 
DWS   Diffusing Wave Spectroscopy 
OER  Oxygen Enhancement Ratio 
FD   Frequency-Domain 
Hb   Deoxygenated hemoglobin 
HbO2   Oxygenated hemoglobin 
HNSCC Head and Neck Squamous Cell Carcinoma 
HPV  Human Papillomavirus 
IR  Incomplete Response 
LDF  Laser Doppler Flowmetry 
LET  Linear Energy Transfer 
MR  Magnetic Resonance 
NIR   Near-Infrared 
OD  Optical Density 
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PDT  Photodynamic Therapy 
PET   Positron Emission Tomography 
PMT   Photomultiplier Tube 
RBC  Red Blood Cell 
SPECT Single-Photon Emission Computed Tomography 
SNR   Signal to Noise Ratio 
SSD  Sum of Squared Differences 
StO2   Tissue Blood Oxygen Saturation 
THC   Total Hemoglobin Concentration 
TR   Time-Resolved 
TTL  Transistor–Transistor Logic 
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